BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer. 2004;4:688-694. [PMID: 15343275 DOI: 10.1038/nrc1433] [Cited by in Crossref: 496] [Cited by in F6Publishing: 476] [Article Influence: 27.6] [Reference Citation Analysis]
Number Citing Articles
1 Park S, Han S, Lee K, Park KH, Cho SW, Hahm K. 5-LOX Inhibitor Modulates the Inflammatory Responses Provoked by Helicobacter pylori Infection. Helicobacter 2007;12. [DOI: 10.1111/j.1523-5378.2007.00469.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
2 Minohara Y, Boyd DK, Hawkins HK, Ernst PB, Patel J, Crowe SE. The effect of the cag pathogenicity island on binding of Helicobacter pylori to gastric epithelial cells and the subsequent induction of apoptosis. Helicobacter 2007;12:583-90. [PMID: 18001397 DOI: 10.1111/j.1523-5378.2007.00537.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
3 Uchida T, Miftahussurur M, Pittayanon R, Vilaichone RK, Wisedopas N, Ratanachu-Ek T, Kishida T, Moriyama M, Yamaoka Y, Mahachai V. Helicobacter pylori Infection in Thailand: A Nationwide Study of the CagA Phenotype. PLoS One. 2015;10:e0136775. [PMID: 26355839 DOI: 10.1371/journal.pone.0136775] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
4 Nešić D, Buti L, Lu X, Stebbins CE. Structure of the Helicobacter pylori CagA oncoprotein bound to the human tumor suppressor ASPP2. Proc Natl Acad Sci U S A 2014;111:1562-7. [PMID: 24474782 DOI: 10.1073/pnas.1320631111] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
5 Subsomwong P, Miftahussurur M, Uchida T, Vilaichone RK, Ratanachu-Ek T, Mahachai V, Yamaoka Y. Prevalence, risk factors, and virulence genes of Helicobacter pylori among dyspeptic patients in two different gastric cancer risk regions of Thailand. PLoS One. 2017;12:e0187113. [PMID: 29084246 DOI: 10.1371/journal.pone.0187113] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
6 Loh JT, Friedman DB, Piazuelo MB, Bravo LE, Wilson KT, Peek RM Jr, Correa P, Cover TL. Analysis of Helicobacter pylori cagA promoter elements required for salt-induced upregulation of CagA expression. Infect Immun 2012;80:3094-106. [PMID: 22710874 DOI: 10.1128/IAI.00232-12] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
7 Bridge DR, Blum FC, Jang S, Kim J, Cha JH, Merrell DS. Creation and Initial Characterization of Isogenic Helicobacter pylori CagA EPIYA Variants Reveals Differential Activation of Host Cell Signaling Pathways. Sci Rep 2017;7:11057. [PMID: 28887533 DOI: 10.1038/s41598-017-11382-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
8 Tahara E. Abnormal growth factor/cytokine network in gastric cancer. Cancer Microenviron 2008;1:85-91. [PMID: 19308687 DOI: 10.1007/s12307-008-0008-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
9 Schneller J, Gupta R, Mustafa J, Villanueva R, Straus EW, Raffaniello RD. Helicobacter pylori infection is associated with a high incidence of intestinal metaplasia in the gastric mucosa of patients at inner-city hospitals in New York. Dig Dis Sci. 2006;51:1801-1809. [PMID: 16944298 DOI: 10.1007/s10620-006-9167-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
10 Chang IY, Kim SH, Cho HJ, Lee DY, Kim MH, Chung MH, You HJ. Human AP endonuclease suppresses DNA mismatch repair activity leading to microsatellite instability. Nucleic Acids Res 2005;33:5073-81. [PMID: 16147991 DOI: 10.1093/nar/gki829] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
11 Lamb A, Chen LF. The many roads traveled by Helicobacter pylori to NFκB activation. Gut Microbes. 2010;1:109-113. [PMID: 21326919 DOI: 10.4161/gmic.1.2.11587] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
12 Wroblewski LE, Peek RM Jr. Helicobacter pylori in gastric carcinogenesis: mechanisms. Gastroenterol Clin North Am 2013;42:285-98. [PMID: 23639641 DOI: 10.1016/j.gtc.2013.01.006] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 8.2] [Reference Citation Analysis]
13 Nishikawa H, Hatakeyama M. Sequence Polymorphism and Intrinsic Structural Disorder as Related to Pathobiological Performance of the Helicobacter pylori CagA Oncoprotein. Toxins (Basel). 2017;9. [PMID: 28406453 DOI: 10.3390/toxins9040136] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
14 Devi SM, Ahmed I, Khan AA, Rahman SA, Alvi A, Sechi LA, Ahmed N. Genomes of Helicobacter pylori from native Peruvians suggest admixture of ancestral and modern lineages and reveal a western type cag-pathogenicity island. BMC Genomics. 2006;7:191. [PMID: 16872520 DOI: 10.1186/1471-2164-7-191] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
15 Gilbreath JJ, Semino-Mora C, Friedline CJ, Liu H, Bodi KL, McAvoy TJ, Francis J, Nieroda C, Sardi A, Dubois A. A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei. Orphanet J Rare Dis. 2013;8:105. [PMID: 23844722 DOI: 10.1186/1750-1172-8-105] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
16 Deng L, He XY, Tang B, Xiang Y, Yue JJ. An improved quantitative real-time polymerase chain reaction technology for Helicobacter pylori detection in stomach tissue and its application value in clinical precision testing. BMC Biotechnol 2020;20:33. [PMID: 32571272 DOI: 10.1186/s12896-020-00624-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Ge R, Shan W. Bacterial phosphoproteomic analysis reveals the correlation between protein phosphorylation and bacterial pathogenicity. Genomics Proteomics Bioinformatics 2011;9:119-27. [PMID: 22196355 DOI: 10.1016/S1672-0229(11)60015-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
18 Kundu M. Helicobacter pylori Peptidyl Prolyl cis, trans Isomerase: A Modulator of the Host Immune Response. In: Henderson B, editor. Moonlighting Cell Stress Proteins in Microbial Infections. Dordrecht: Springer Netherlands; 2013. pp. 81-91. [DOI: 10.1007/978-94-007-6787-4_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Kauser F, Hussain MA, Ahmed I, Srinivas S, Devi SM, Majeed AA, Rao KR, Khan AA, Sechi LA, Ahmed N. Comparative genomics of Helicobacter pylori isolates recovered from ulcer disease patients in England. BMC Microbiol. 2005;5:32. [PMID: 15916705 DOI: 10.1186/1471-2180-5-32] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 1.7] [Reference Citation Analysis]
20 Salemme V, Angelini C, Chapelle J, Centonze G, Natalini D, Morellato A, Taverna D, Turco E, Ala U, Defilippi P. The p140Cap adaptor protein as a molecular hub to block cancer aggressiveness. Cell Mol Life Sci 2021;78:1355-67. [PMID: 33079227 DOI: 10.1007/s00018-020-03666-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Rivas-Ortiz CI, Lopez-Vidal Y, Arredondo-Hernandez LJR, Castillo-Rojas G. Genetic Alterations in Gastric Cancer Associated with <i>Helicobacter pylori</i> Infection. Front Med (Lausanne). 2017;4:47. [PMID: 28512631 DOI: 10.3389/fmed.2017.00047] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
22 Matteo MJ, Granados G, Pérez CV, Olmos M, Sanchez C, Catalano M. Helicobacter pylori cag pathogenicity island genotype diversity within the gastric niche of a single host. J Med Microbiol 2007;56:664-9. [PMID: 17446291 DOI: 10.1099/jmm.0.46885-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
23 Jones KR, Jang S, Chang JY, Kim J, Chung IS, Olsen CH, Merrell DS, Cha JH. Polymorphisms in the intermediate region of VacA impact Helicobacter pylori-induced disease development. J Clin Microbiol 2011;49:101-10. [PMID: 21084502 DOI: 10.1128/JCM.01782-10] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
24 Yasuda A, Uchida T, Nguyen LT, Kawazato H, Tanigawa M, Murakami K, Kishida T, Fujioka T, Moriyama M. A novel diagnostic monoclonal antibody specific for Helicobacter pylori CagA of East Asian type. APMIS 2009;117:893-9. [PMID: 20078554 DOI: 10.1111/j.1600-0463.2009.02548.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
25 Lochhead P, El-Omar EM. Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol. 2007;21:281-297. [PMID: 17382277 DOI: 10.1016/j.bpg.2007.02.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
26 Yuan XY, Yan JJ, Yang YC, Wu CM, Hu Y, Geng JL. Helicobacter pylori with East Asian-type cagPAI genes is more virulent than strains with Western-type in some cagPAI genes. Braz J Microbiol 2017;48:218-24. [PMID: 28130020 DOI: 10.1016/j.bjm.2016.12.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
27 Zhan X, Dong H, Sun C, Liu L, Wang D, Wei Z. [Expression and clinical significance of SHP2 in the tumor tissues of smokers with lung cancer]. Zhongguo Fei Ai Za Zhi 2010;13:877-81. [PMID: 20840817 DOI: 10.3779/j.issn.1009-3419.2010.09.08] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Gwack J, Shin A, Kim CS, Ko KP, Kim Y, Jun JK, Bae J, Park SK, Hong YC, Kang D. CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea. Br J Cancer. 2006;95:639-641. [PMID: 16909137 DOI: 10.1038/sj.bjc.6603309] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
29 Hatakeyama M. Linking epithelial polarity and carcinogenesis by multitasking Helicobacter pylori virulence factor CagA. Oncogene. 2008;27:7047-7054. [PMID: 19029944 DOI: 10.1038/onc.2008.353] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 4.2] [Reference Citation Analysis]
30 Nguyen LT, Uchida T, Kuroda A, Tsukamoto Y, Trinh TD, Ta L, Mai HB, Ho DQ, Hoang HH, Vilaichone RK, Mahachai V, Matsuhisa T, Kudo Y, Okimoto T, Kodama M, Murakami K, Fujioka T, Yamaoka Y, Moriyama M. Evaluation of the anti-East Asian CagA-specific antibody for CagA phenotyping. Clin Vaccine Immunol 2009;16:1687-92. [PMID: 19776193 DOI: 10.1128/CVI.00200-09] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
31 Ladeira MS, Bueno RC, Dos Santos BF, Pinto CL, Prado RP, Silveira MG, Rodrigues MA, Bartchewsky W, Pedrazzoli J, Ribeiro ML. Relationship among oxidative DNA damage, gastric mucosal density and the relevance of cagA, vacA and iceA genotypes of Helicobacter pylori. Dig Dis Sci. 2008;53:248-255. [PMID: 17520364 DOI: 10.1007/s10620-007-9850-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
32 Chen CY, Wang FY, Wan HJ, Jin XX, Wei J, Wang ZK, Liu C, Lu H, Shi H, Li DH. Amino acid polymorphisms flanking the EPIYA-A motif of Helicobacter pylori CagA C-terminal region is associated with gastric cancer in east China: experience from a single center. J Dig Dis. 2013;14:358-365. [PMID: 23517408 DOI: 10.1111/1751-2980.12056] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
33 McClain MS, Duncan SS, Gaddy JA, Cover TL. Control of gene expression in Helicobacter pylori using the Tet repressor. J Microbiol Methods 2013;95:336-41. [PMID: 24113399 DOI: 10.1016/j.mimet.2013.09.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
34 Li J, Ou Z, Wang F, Guo Y, Zhang R, Zhang J, Li P, Xu W, He Y. Distinctiveness of the cagA genotype in children and adults with peptic symptoms in South China. Helicobacter 2009;14:248-55. [PMID: 19674128 DOI: 10.1111/j.1523-5378.2009.00690.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
35 Loh JT, Lin AS, Beckett AC, McClain MS, Cover TL. Role of a Stem-Loop Structure in Helicobacter pylori cagA Transcript Stability. Infect Immun 2019;87:e00692-18. [PMID: 30510104 DOI: 10.1128/IAI.00692-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
36 Yuan XY, Wang Y, Wang MY. The type IV secretion system in Helicobacter pylori. Future Microbiol 2018;13:1041-54. [PMID: 29927340 DOI: 10.2217/fmb-2018-0038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
37 Wu J, Xu S, Zhu Y. Helicobacter pylori CagA: a critical destroyer of the gastric epithelial barrier. Dig Dis Sci. 2013;58:1830-1837. [PMID: 23423500 DOI: 10.1007/s10620-013-2589-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
38 Murata-Kamiya N, Kikuchi K, Hayashi T, Higashi H, Hatakeyama M. Helicobacter pylori exploits host membrane phosphatidylserine for delivery, localization, and pathophysiological action of the CagA oncoprotein. Cell Host Microbe. 2010;7:399-411. [PMID: 20478541 DOI: 10.1016/j.chom.2010.04.005] [Cited by in Crossref: 115] [Cited by in F6Publishing: 109] [Article Influence: 9.6] [Reference Citation Analysis]
39 Suzuki H, Mori H. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. J Gastroenterol. 2018;53:354-361. [PMID: 29138921 DOI: 10.1007/s00535-017-1407-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 12.2] [Reference Citation Analysis]
40 Figura N, Marano L, Moretti E, Ponzetto A. Helicobacter pylori infection and gastric carcinoma: Not all the strains and patients are alike. World J Gastrointest Oncol 2016; 8(1): 40-54 [PMID: 26798436 DOI: 10.4251/wjgo.v8.i1.40] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
41 Tomioka N, Morita K, Kobayashi N, Tada M, Itoh T, Saitoh S, Kondo M, Takahashi N, Kataoka A, Nakanishi K. Array comparative genomic hybridization analysis revealed four genomic prognostic biomarkers for primary gastric cancers. Cancer Genet Cytogenet. 2010;201:6-14. [PMID: 20633762 DOI: 10.1016/j.cancergencyto.2010.04.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
42 Ahmed N, Dobrindt U, Hacker J, Hasnain SE. Genomic fluidity and pathogenic bacteria: applications in diagnostics, epidemiology and intervention. Nat Rev Microbiol 2008;6:387-94. [PMID: 18392032 DOI: 10.1038/nrmicro1889] [Cited by in Crossref: 110] [Cited by in F6Publishing: 104] [Article Influence: 7.9] [Reference Citation Analysis]
43 Testerman TL, Semino-Mora C, Cann JA, Qiang B, Peña EA, Liu H, Olsen CH, Chen H, Appt SE, Kaplan JR, Register TC, Merrell DS, Dubois A. Both diet and Helicobacter pylori infection contribute to atherosclerosis in pre- and postmenopausal cynomolgus monkeys. PLoS One 2019;14:e0222001. [PMID: 31490998 DOI: 10.1371/journal.pone.0222001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
44 Tseng PC, Chen CL, Shan YS, Lin CF. An increase in galectin-3 causes cellular unresponsiveness to IFN-γ-induced signal transduction and growth inhibition in gastric cancer cells. Oncotarget 2016;7:15150-60. [PMID: 26934444 DOI: 10.18632/oncotarget.7750] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
45 Kuzuhara T, Suganuma M, Oka K, Fujiki H. DNA-binding activity of TNF-αlpha inducing protein from Helicobacter pylori. Biochem Biophys Res Commun. 2007;362:805-810. [PMID: 17765875 DOI: 10.1016/j.bbrc.2007.08.058] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
46 Szymczak A, Ferenc S, Majewska J, Miernikiewicz P, Gnus J, Witkiewicz W, Dąbrowska K. Application of 16S rRNA gene sequencing in Helicobacter pylori detection. PeerJ 2020;8:e9099. [PMID: 32440373 DOI: 10.7717/peerj.9099] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
47 Gao L, Weck MN, Nieters A, Brenner H. Grb2-associated binder 1 (Gab1) genetic polymorphism, Helicobacter pylori infection, and chronic atrophic gastritis among older adults from Germany. Mol Carcinog 2010;49:869-73. [PMID: 20602450 DOI: 10.1002/mc.20662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Alzahrani S, Lina TT, Gonzalez J, Pinchuk IV, Beswick EJ, Reyes VE. Effect of Helicobacter pylori on gastric epithelial cells. World J Gastroenterol 2014; 20(36): 12767-12780 [PMID: 25278677 DOI: 10.3748/wjg.v20.i36.12767] [Cited by in CrossRef: 68] [Cited by in F6Publishing: 55] [Article Influence: 8.5] [Reference Citation Analysis]
49 Matsunari O, Shiota S, Suzuki R, Watada M, Kinjo N, Murakami K, Fujioka T, Kinjo F, Yamaoka Y. Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J Clin Microbiol 2012;50:876-83. [PMID: 22189111 DOI: 10.1128/JCM.05562-11] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 6.2] [Reference Citation Analysis]
50 Alebouyeh M, Vaziri F, Peerayeh SN, Siadat SD. A letter to the editor comment on: Five-year monitoring of considerable changes in tyrosine phosphorylation motifs of the Helicobacter pylori cagA gene in Iran. J Appl Genet 2015;56:147. [PMID: 25323795 DOI: 10.1007/s13353-014-0248-3] [Reference Citation Analysis]
51 Sahara S, Sugimoto M, Vilaichone RK, Mahachai V, Miyajima H, Furuta T, Yamaoka Y. Role of Helicobacter pylori cagA EPIYA motif and vacA genotypes for the development of gastrointestinal diseases in Southeast Asian countries: a meta-analysis. BMC Infect Dis. 2012;12:223. [PMID: 22994150 DOI: 10.1186/1471-2334-12-223] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
52 Shokrzadeh L, Baghaei K, Yamaoka Y, Dabiri H, Jafari F, Sahebekhtiari N, Tahami A, Sugimoto M, Zojaji H, Zali MR. Analysis of 3'-end variable region of the cagA gene in Helicobacter pylori isolated from Iranian population. J Gastroenterol Hepatol 2010;25:172-7. [PMID: 19793167 DOI: 10.1111/j.1440-1746.2009.05979.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
53 Zhao D, Liu Z, Ding J, Li W, Sun Y, Yu H, Zhou Y, Zeng J, Chen C, Jia J. Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways. J Med Microbiol. 2010;59:259-265. [PMID: 19959630 DOI: 10.1099/jmm.0.014704-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
54 Yu J, Fu B, Zhao Q. Family history of malignant neoplasm and its relation with clinicopathologic features of gastric cancer patients. World J Surg Oncol 2013;11:201. [PMID: 23953708 DOI: 10.1186/1477-7819-11-201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Gao P, Cai N, Yang X, Yuan Z, Zhang T, Lu M, Jin L, Ye W, Suo C, Chen X. Association of Helicobacter pylori and gastric atrophy with adenocarcinoma of the esophagogastric junction in Taixing, China. Int J Cancer 2021. [PMID: 34498732 DOI: 10.1002/ijc.33801] [Reference Citation Analysis]
56 Marasco M, Berteotti A, Weyershaeuser J, Thorausch N, Sikorska J, Krausze J, Brandt HJ, Kirkpatrick J, Rios P, Schamel WW, Köhn M, Carlomagno T. Molecular mechanism of SHP2 activation by PD-1 stimulation. Sci Adv 2020;6:eaay4458. [PMID: 32064351 DOI: 10.1126/sciadv.aay4458] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 20.5] [Reference Citation Analysis]
57 Katoh H, Ishikawa S. Genomic pathobiology of gastric carcinoma: Genomic Profile of Gastric Carcinoma. Pathol Int 2017;67:63-71. [DOI: 10.1111/pin.12493] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
58 Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23:713-739. [PMID: 20930071 DOI: 10.1128/cmr.00011-10] [Cited by in Crossref: 680] [Cited by in F6Publishing: 383] [Article Influence: 56.7] [Reference Citation Analysis]
59 Peter S, Beglinger C. Helicobacter pylori and gastric cancer: the causal relationship. Digestion. 2007;75:25-35. [PMID: 17429205 DOI: 10.1159/000101564] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
60 Jiménez-Soto LF, Kutter S, Sewald X, Ertl C, Weiss E, Kapp U, Rohde M, Pirch T, Jung K, Retta SF. Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner. PLoS Pathog. 2009;5:e1000684. [PMID: 19997503 DOI: 10.1371/journal.ppat.1000684.t001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 He C, Chen M, Liu J, Yuan Y. Host genetic factors respond to pathogenic step-specific virulence factors of Helicobacter pylori in gastric carcinogenesis. Mutat Res Rev Mutat Res. 2014;759:14-26. [PMID: 24076409 DOI: 10.1016/j.mrrev.2013.09.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
62 McClain MS, Shaffer CL, Israel DA, Peek RM Jr, Cover TL. Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer. BMC Genomics 2009;10:3. [PMID: 19123947 DOI: 10.1186/1471-2164-10-3] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 6.0] [Reference Citation Analysis]
63 Lorenzo I, Fernández-de-Larrea N, Michel A, Romero B, Lope V, Bessa X, Moreno V, Martín V, Amiano P, Castilla J, Tardón A, Dierssen-Sotos T, Peiró R, Díaz-Santos M, Navarro C, Jiménez-Moleón JJ, Butt J, Barricarte A, Ruiz I, Molina-de-la-Torre AJ, Casabonne D, Pérez-Gómez B, Kogevinas M, Del Campo R, de Sanjosé S, Pollán M, Waterboer T, Aragonés N. Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors. Eur J Cancer Prev 2019;28:294-303. [PMID: 30489354 DOI: 10.1097/CEJ.0000000000000483] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
64 Oliveira AKS, Silva LLL, Miguel MP, Blanco AJV, Carneiro LC, Barbosa MS. HELICOBACTER PYLORI cagA VIRULENCE GENE AND SEVERE ESOGASTRODUODENAL DISEASES: IS THERE AN ASSOCIATION? Arq Gastroenterol 2021;58:468-75. [PMID: 34909852 DOI: 10.1590/S0004-2803.202100000-85] [Reference Citation Analysis]
65 Hayashi T, Morohashi H, Hatakeyama M. Bacterial EPIYA effectors--where do they come from? What are they? Where are they going? Cell Microbiol 2013;15:377-85. [PMID: 23051602 DOI: 10.1111/cmi.12040] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
66 Ishikawa S, Ohta T, Hatakeyama M. Stability of Helicobacter pylori CagA oncoprotein in human gastric epithelial cells. FEBS Lett 2009;583:2414-8. [PMID: 19560464 DOI: 10.1016/j.febslet.2009.06.043] [Cited by in F6Publishing: 21] [Reference Citation Analysis]
67 Ahmed N. Coevolution and adaptation of Helicobacter pylori and the case for 'functional molecular infection epidemiology'. Med Princ Pract 2011;20:497-503. [PMID: 21986005 DOI: 10.1159/000329786] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
68 Elson A. Stepping out of the shadows: Oncogenic and tumor-promoting protein tyrosine phosphatases. Int J Biochem Cell Biol 2018;96:135-47. [PMID: 28941747 DOI: 10.1016/j.biocel.2017.09.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
69 Shaffer CL, Gaddy JA, Loh JT, Johnson EM, Hill S, Hennig EE, McClain MS, McDonald WH, Cover TL. Helicobacter pylori exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacteria-host cell interface. PLoS Pathog 2011;7:e1002237. [PMID: 21909278 DOI: 10.1371/journal.ppat.1002237] [Cited by in Crossref: 118] [Cited by in F6Publishing: 112] [Article Influence: 10.7] [Reference Citation Analysis]
70 Aziz F, Khan I, Shukla S, Dey DK, Yan Q, Chakraborty A, Yoshitomi H, Hwang SK, Sonwal S, Lee H, Haldorai Y, Xiao J, Huh YS, Bajpai VK, Han YK. Partners in crime: The Lewis Y antigen and fucosyltransferase IV in Helicobacter pylori-induced gastric cancer. Pharmacol Ther 2021;:107994. [PMID: 34571111 DOI: 10.1016/j.pharmthera.2021.107994] [Reference Citation Analysis]
71 Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY, Gao F. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J Gastroenterol 2021; 27(27): 4298-4321 [PMID: 34366606 DOI: 10.3748/wjg.v27.i27.4298] [Reference Citation Analysis]
72 Joly S, Compton LM, Pujol C, Kurago ZB, Guthmiller JM. Loss of human β-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiology and Immunology 2009;24:353-60. [DOI: 10.1111/j.1399-302x.2009.00512.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
73 Barrow A, Trowsdale J. You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling. Eur J Immunol 2006;36:1646-53. [DOI: 10.1002/eji.200636195] [Cited by in Crossref: 170] [Cited by in F6Publishing: 167] [Article Influence: 10.6] [Reference Citation Analysis]
74 Johnson EM, Gaddy JA, Cover TL. Alterations in Helicobacter pylori triggered by contact with gastric epithelial cells. Front Cell Infect Microbiol 2012;2:17. [PMID: 22919609 DOI: 10.3389/fcimb.2012.00017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
75 Srivastava AK, Tewari M, Shukla HS, Roy BK. In Silico Profiling of the Potentiality of Curcumin and Conventional Drugs for CagA Oncoprotein Inactivation: In Silico Profiling of CagA Oncoprotein Inactivation Potential. Arch Pharm Chem Life Sci 2015;348:548-55. [DOI: 10.1002/ardp.201400438] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
76 Zhu Y, Jiang Q, Lou X, Ji X, Wen Z, Wu J, Tao H, Jiang T, He W, Wang C. MicroRNAs up-regulated by CagA of Helicobacter pylori induce intestinal metaplasia of gastric epithelial cells. PLoS One. 2012;7:e35147. [PMID: 22536353 DOI: 10.1371/journal.pone.0035147] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
77 Nagashima H, Iwatani S, Cruz M, Jiménez Abreu JA, Tronilo L, Rodríguez E, Disla M, Terao H, Uchida T, Mahachai V, Vilaichone RK, Tshering L, Mitsui T, Shiota S, Graham DY, Yamaoka Y. Differences in interleukin 8 expression in Helicobacter pylori-infected gastric mucosa tissues from patients in Bhutan and the Dominican Republic. Hum Pathol 2015;46:129-36. [PMID: 25454482 DOI: 10.1016/j.humpath.2014.10.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
78 Kang DW, Choi KY, Min DS. Functional regulation of phospholipase D expression in cancer and inflammation. J Biol Chem 2014;289:22575-82. [PMID: 24990948 DOI: 10.1074/jbc.R114.569822] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
79 Schmidt HA, Goh K, Fock KM, Hilmi I, Dhamodaran S, Forman D, Mitchell H. Distinct cagA EPIYA Motifs are Associated with Ethnic Diversity in Malaysia and Singapore. Helicobacter 2009;14:256-63. [DOI: 10.1111/j.1523-5378.2009.00684.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
80 Ketpueak T, Thiennimitr P, Apaijai N, Chattipakorn SC, Chattipakorn N. Association of Chronic Opisthorchis Infestation and Microbiota Alteration on Tumorigenesis in Cholangiocarcinoma. Clin Transl Gastroenterol 2020;12:e00292. [PMID: 33464733 DOI: 10.14309/ctg.0000000000000292] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Yanovich O, Doroshko M, Titov L. Helicobacter pylori genotypes among Belarus patients with gastroduodenal disorders and their association with clinical outcome. Acta Microbiol Immunol Hung 2019;66:399-411. [PMID: 31096759 DOI: 10.1556/030.66.2019.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
82 Nishikawa J, Iizasa H, Yoshiyama H, Shimokuri K, Kobayashi Y, Sasaki S, Nakamura M, Yanai H, Sakai K, Suehiro Y, Yamasaki T, Sakaida I. Clinical Importance of Epstein⁻Barr Virus-Associated Gastric Cancer. Cancers (Basel) 2018;10:E167. [PMID: 29843478 DOI: 10.3390/cancers10060167] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 9.5] [Reference Citation Analysis]
83 Giordano A, Cito L. Advances in gastric cancer prevention. World J Clin Oncol 2012; 3(9): 128-136 [PMID: 23061031 DOI: 10.5306/wjco.v3.i9.128] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
84 Takahashi A, Tsutsumi R, Kikuchi I, Obuse C, Saito Y, Seidi A, Karisch R, Fernandez M, Cho T, Ohnishi N, Rozenblatt-Rosen O, Meyerson M, Neel BG, Hatakeyama M. SHP2 tyrosine phosphatase converts parafibromin/Cdc73 from a tumor suppressor to an oncogenic driver. Mol Cell 2011;43:45-56. [PMID: 21726809 DOI: 10.1016/j.molcel.2011.05.014] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 5.9] [Reference Citation Analysis]
85 Isomoto H, Nishi Y, Ohnita K, Mizuta Y, Kohno S, Ueno H, Nakazato M. The Relationship between Plasma and Gastric Ghrelin Levels and Strain Diversity in Helicobacter pylori Virulence. Am J Gastroenterol 2005;100:1425-7. [PMID: 15929785 DOI: 10.1111/j.1572-0241.2005.41929_7.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
86 He C, Tu H, Sun L, Xu Q, Gong Y, Jing J, Dong N, Yuan Y. SNP interactions of Helicobacter pylori-related host genes PGC, PTPN11, IL1B, and TLR4 in susceptibility to gastric carcinogenesis. Oncotarget. 2015;6:19017-19026. [PMID: 26158864 DOI: 10.18632/oncotarget.4231] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
87 Ma L, Zeng J, Guo Q, Liang X, Shen L, Li S, Sun Y, Li W, Liu S, Yu H, Chen C, Jia J. Mutual amplification of HNF4α and IL-1R1 composes an inflammatory circuit in Helicobacter pylori associated gastric carcinogenesis. Oncotarget 2016;7:11349-63. [PMID: 26870992 DOI: 10.18632/oncotarget.7239] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
88 Miftahussurur M, Syam AF, Makmun D, Nusi IA, Zein LH, Zulkhairi F, Uswan WB, Simanjuntak D, Uchida T, Adi P. Helicobacter pylori virulence genes in the five largest islands of Indonesia. Gut Pathog. 2015;7:26. [PMID: 26442711 DOI: 10.1186/s13099-015-0072-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
89 Kim SS, Shetty K, Katuri V, Kitisin K, Baek HJ, Tang Y, Marshall B, Johnson L, Mishra B, Mishra L. TGF-beta signaling pathway inactivation and cell cycle deregulation in the development of gastric cancer: role of the beta-spectrin, ELF. Biochem Biophys Res Commun. 2006;344:1216-1223. [PMID: 16650383 DOI: 10.1016/j.bbrc.2006.03.236] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
90 Bakhti SZ, Latifi-Navid S, Safaralizadeh R. Helicobacter pylori-related risk predictors of gastric cancer: The latest models, challenges, and future prospects. Cancer Med 2020;9:4808-22. [PMID: 32363738 DOI: 10.1002/cam4.3068] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
91 Blank U, Launay P, Benhamou M, Monteiro RC. Inhibitory ITAMs as novel regulators of immunity. Immunological Reviews 2009;232:59-71. [DOI: 10.1111/j.1600-065x.2009.00832.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 63] [Article Influence: 8.9] [Reference Citation Analysis]
92 Arimoto-kobayashi S, Ohta K, Yuhara Y, Ayabe Y, Negishi T, Okamoto K, Nakajima Y, Ishikawa T, Oguma K, Otsuka T. Mutagenicity and clastogenicity of extracts of Helicobacter pylori detected by the Ames test and in the micronucleus test using human lymphoblastoid cells. Mutagenesis 2015;30:537-44. [DOI: 10.1093/mutage/gev016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
93 Dehio C. Bartonella–host-cell interactions and vascular tumour formation. Nat Rev Microbiol 2005;3:621-31. [DOI: 10.1038/nrmicro1209] [Cited by in Crossref: 106] [Cited by in F6Publishing: 91] [Article Influence: 6.2] [Reference Citation Analysis]
94 Nishikawa H, Hayashi T, Arisaka F, Senda T, Hatakeyama M. Impact of structural polymorphism for the Helicobacter pylori CagA oncoprotein on binding to polarity-regulating kinase PAR1b. Sci Rep 2016;6:30031. [PMID: 27445265 DOI: 10.1038/srep30031] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
95 Basso D, Zambon C, Letley DP, Stranges A, Marchet A, Rhead JL, Schiavon S, Guariso G, Ceroti M, Nitti D, Rugge M, Plebani M, Atherton JC. Clinical Relevance of Helicobacter pylori cagA and vacA Gene Polymorphisms. Gastroenterology 2008;135:91-9. [DOI: 10.1053/j.gastro.2008.03.041] [Cited by in Crossref: 263] [Cited by in F6Publishing: 245] [Article Influence: 18.8] [Reference Citation Analysis]
96 Wada R, Akiyama Y, Hashimoto Y, Fukamachi H, Yuasa Y. miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer. Int J Cancer 2010;127:1106-14. [DOI: 10.1002/ijc.25126] [Cited by in Crossref: 91] [Cited by in F6Publishing: 98] [Article Influence: 7.0] [Reference Citation Analysis]
97 Hayward RD, Hume PJ, Humphreys D, Phillips N, Smith K, Koronakis V. Clustering transfers the translocated Escherichia coli receptor into lipid rafts to stimulate reversible activation of c-Fyn. Cellular Microbiology 2009;11:433-41. [DOI: 10.1111/j.1462-5822.2008.01265.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
98 Horridge DN, Begley AA, Kim J, Aravindan N, Fan K, Forsyth MH. Outer inflammatory protein a (OipA) of Helicobacter pylori is regulated by host cell contact and mediates CagA translocation and interleukin-8 response only in the presence of a functional cag pathogenicity island type IV secretion system. Pathog Dis. 2017;75. [PMID: 29040466 DOI: 10.1093/femspd/ftx113] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
99 Yang JY, Kim P, Jeong SH, Lee SW, Myung YS, Baeg MK, Kim JB. The Effects of Sulglycotide on the Adhesion and the Inflammation of Helicobacter Pylori. Int J Environ Res Public Health 2020;17:E2918. [PMID: 32340212 DOI: 10.3390/ijerph17082918] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Ito T, Sakurai-Yageta M, Goto A, Pairojkul C, Yongvanit P, Murakami Y. Genomic and transcriptional alterations of cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2014;21:380-7. [PMID: 24532422 DOI: 10.1002/jhbp.67] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
101 Aftab H, Miftahussurur M, Subsomwong P, Ahmed F, Khan AKA, Matsumoto T, Suzuki R, Yamaoka Y. Two populations of less-virulent Helicobacter pylori genotypes in Bangladesh. PLoS One. 2017;12:e0182947. [PMID: 28797101 DOI: 10.1371/journal.pone.0182947] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
102 Olbermann P, Josenhans C, Moodley Y, Uhr M, Stamer C, Vauterin M, Suerbaum S, Achtman M, Linz B. A global overview of the genetic and functional diversity in the Helicobacter pylori cag pathogenicity island. PLoS Genet. 2010;6:e1001069. [PMID: 20808891 DOI: 10.1371/journal.pgen.1001069] [Cited by in Crossref: 138] [Cited by in F6Publishing: 131] [Article Influence: 11.5] [Reference Citation Analysis]
103 Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, De Poire E, Sgouras D, Wessler S, Torres J, Smolka A, Backert S. c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest. 2012;122:1553-1566. [PMID: 22378042 DOI: 10.1172/jci61143] [Cited by in Crossref: 158] [Cited by in F6Publishing: 112] [Article Influence: 15.8] [Reference Citation Analysis]
104 Hashi K, Imai C, Yahara K, Tahmina K, Hayashi T, Azuma T, Miyabe-Nishiwaki T, Sato H, Matsuoka M, Niimi S, Okamoto M, Hatakeyama M. Evaluating the origin and virulence of a Helicobacter pylori cagA-positive strain isolated from a non-human primate. Sci Rep 2018;8:15981. [PMID: 30374120 DOI: 10.1038/s41598-018-34425-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
105 Malfertheiner P, Link A, Selgrad M. Helicobacter pylori: perspectives and time trends. Nat Rev Gastroenterol Hepatol. 2014;11:628-638. [PMID: 25001975 DOI: 10.1038/nrgastro.2014.99] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 10.3] [Reference Citation Analysis]
106 Flores-Treviño CE, Urrutia-Baca VH, Gómez-Flores R, De La Garza-Ramos MA, Sánchez-Chaparro MM, Garza-Elizondo MA. Molecular detection of Helicobacter pylori based on the presence of cagA and vacA virulence genes in dental plaque from patients with periodontitis. J Dent Sci 2019;14:163-70. [PMID: 31210890 DOI: 10.1016/j.jds.2019.01.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
107 Johnson EM, Gaddy JA, Voss BJ, Hennig EE, Cover TL. Genes required for assembly of pili associated with the Helicobacter pylori cag type IV secretion system. Infect Immun. 2014;82:3457-3470. [PMID: 24891108 DOI: 10.1128/iai.01640-14] [Cited by in Crossref: 55] [Cited by in F6Publishing: 37] [Article Influence: 6.9] [Reference Citation Analysis]
108 Sekiguchi H, Washida K, Murakami A. Suppressive Effects of Selected Food Phytochemicals on CD74 Expression in NCI-N87 Gastric Carcinoma Cells. J Clin Biochem Nutr. 2008;43:109-117. [PMID: 18818744 DOI: 10.3164/jcbn.2008054] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
109 Torres K, Valderrama E, Sayegh M, Ramírez JL, Chiurillo MA. Study of the oipA genetic diversity and EPIYA motif patterns in cagA-positive Helicobacter pylori strains from Venezuelan patients with chronic gastritis. Microb Pathog 2014;76:26-32. [PMID: 25223715 DOI: 10.1016/j.micpath.2014.09.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
110 Hanafiah A, Lopes BS. Genetic diversity and virulence characteristics of Helicobacter pylori isolates in different human ethnic groups. Infect Genet Evol 2020;78:104135. [PMID: 31837482 DOI: 10.1016/j.meegid.2019.104135] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Bonsor DA, Zhao Q, Schmidinger B, Weiss E, Wang J, Deredge D, Beadenkopf R, Dow B, Fischer W, Beckett D, Wintrode PL, Haas R, Sundberg EJ. The Helicobacter pylori adhesin protein HopQ exploits the dimer interface of human CEACAMs to facilitate translocation of the oncoprotein CagA. EMBO J 2018;37:e98664. [PMID: 29724755 DOI: 10.15252/embj.201798664] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
112 Saniee P, Jalili S, Ghadersoltani P, Daliri L, Siavoshi F. Individual hosts carry H. pylori isolates with different cagA features - motifs and copy number. Infect Genet Evol 2021;93:104961. [PMID: 34119688 DOI: 10.1016/j.meegid.2021.104961] [Reference Citation Analysis]
113 Ahmed N, Sechi LA. Helicobacter pylori and gastroduodenal pathology: new threats of the old friend. Ann Clin Microbiol Antimicrob. 2005;4:1. [PMID: 15634357 DOI: 10.1186/1476-0711-4-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
114 Yang Z, Xue B, Umitsu M, Ikura M, Muthuswamy SK, Neel BG. The signaling adaptor GAB1 regulates cell polarity by acting as a PAR protein scaffold. Mol Cell 2012;47:469-83. [PMID: 22883624 DOI: 10.1016/j.molcel.2012.06.037] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
115 Wu H, Fu M, Liu J, Chong W, Fang Z, Du F, Liu Y, Shang L, Li L. The role and application of small extracellular vesicles in gastric cancer. Mol Cancer 2021;20:71. [PMID: 33926452 DOI: 10.1186/s12943-021-01365-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
116 Kikuchi K, Murata-Kamiya N, Kondo S, Hatakeyama M. Helicobacter pylori stimulates epithelial cell migration via CagA-mediated perturbation of host cell signaling. Microbes Infect. 2012;14:470-476. [PMID: 22202178 DOI: 10.1016/j.micinf.2011.12.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
117 Cheng Y, Xiao Y, Zhou R, Liao Y, Zhou J, Ma X. Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma. BMC Cancer 2019;19:842. [PMID: 31455250 DOI: 10.1186/s12885-019-6067-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
118 Nguyen LT, Uchida T, Murakami K, Fujioka T, Moriyama M. Helicobacter pylori virulence and the diversity of gastric cancer in Asia. J Med Microbiol. 2008;57:1445-1453. [PMID: 19018013 DOI: 10.1099/jmm.0.2008/003160-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
119 Zhou X, Wu J, Zhang G. Association between Helicobacter pylori and asthma: a meta-analysis. Eur J Gastroenterol Hepatol. 2013;25:460-468. [PMID: 23242126 DOI: 10.1097/meg.0b013e32835c280a] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
120 Keilberg D, Ottemann KM. How Helicobacter pylori senses, targets and interacts with the gastric epithelium: H. pylori -gastric epithelium interaction. Environ Microbiol 2016;18:791-806. [DOI: 10.1111/1462-2920.13222] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
121 Nagase L, Hayashi T, Senda T, Hatakeyama M. Dramatic increase in SHP2 binding activity of Helicobacter pylori Western CagA by EPIYA-C duplication: its implications in gastric carcinogenesis. Sci Rep 2015;5:15749. [PMID: 26507409 DOI: 10.1038/srep15749] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
122 Ponzetto A, Diella FA, Holton J. Aetiology of hepatocellular carcinoma in South America. Liver Int 2018;38:956-7. [DOI: 10.1111/liv.13703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
123 Hatakeyama M. Helicobacter pylori CagA -- a bacterial intruder conspiring gastric carcinogenesis. Int J Cancer. 2006;119:1217-1223. [PMID: 16557568 DOI: 10.1002/ijc.21831] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 4.4] [Reference Citation Analysis]
124 Monack DM. Helicobacter and salmonella persistent infection strategies. Cold Spring Harb Perspect Med. 2013;3:a010348. [PMID: 24296347 DOI: 10.1101/cshperspect.a010348] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
125 Khatoon J, Rai RP, Prasad KN. Role of Helicobacter pylori in gastric cancer: Updates. World J Gastrointest Oncol 2016; 8(2): 147-158 [PMID: 26909129 DOI: 10.4251/wjgo.v8.i2.147] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
126 Lina TT, Pinchuk IV, House J, Yamaoka Y, Graham DY, Beswick EJ, Reyes VE. CagA-dependent downregulation of B7-H2 expression on gastric mucosa and inhibition of Th17 responses during Helicobacter pylori infection. J Immunol. 2013;191:3838-3846. [PMID: 23997227 DOI: 10.4049/jimmunol.1300524] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
127 Tsang YH, Lamb A, Romero-Gallo J, Huang B, Ito K, Peek RM Jr, Ito Y, Chen LF. Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation. Oncogene 2010;29:5643-50. [PMID: 20676134 DOI: 10.1038/onc.2010.304] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 5.6] [Reference Citation Analysis]
128 Gonzalez-Rivera C, Bhatty M, Christie PJ. Mechanism and Function of Type IV Secretion During Infection of the Human Host. Microbiol Spectr 2016;4. [PMID: 27337453 DOI: 10.1128/microbiolspec.VMBF-0024-2015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
129 Belair C, Baud J, Chabas S, Sharma CM, Vogel J, Staedel C, Darfeuille F. Helicobacter pylori interferes with an embryonic stem cell micro RNA cluster to block cell cycle progression. Silence. 2011;2:7. [PMID: 22027184 DOI: 10.1186/1758-907x-2-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
130 Farinha P, Gascoyne RD. Helicobacter pylori and MALT lymphoma. Gastroenterology. 2005;128:1579-1605. [PMID: 15887153 DOI: 10.1053/j.gastro.2005.03.083] [Cited by in Crossref: 117] [Cited by in F6Publishing: 98] [Article Influence: 6.9] [Reference Citation Analysis]
131 Robinson K, Argent RH, Atherton JC. The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol. 2007;21:237-259. [PMID: 17382275 DOI: 10.1016/j.bpg.2007.01.001] [Cited by in Crossref: 109] [Cited by in F6Publishing: 99] [Article Influence: 7.3] [Reference Citation Analysis]
132 Siomek A, Rytarowska A, Szaflarska-poplawska A, Gackowski D, Rozalski R, Dziaman T, Czerwionka-szaflarska M, Olinski R. Helicobacter pylori infection is associated with oxidatively damaged DNA in human leukocytes and decreased level of urinary 8-oxo-7,8-dihydroguanine. Carcinogenesis 2006;27:405-8. [DOI: 10.1093/carcin/bgi238] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
133 Zhao Y, Zhou Y, Sun Y, Yu A, Yu H, Li W, Liu Z, Zeng J, Li X, Chen C, Jia J. Virulence factor cytotoxin-associated gene A in Helicobacter pylori is downregulated by interferon-γin vitro: Helicobacter pylori CagA downregulated by IFN-γ. FEMS Immunology & Medical Microbiology 2011;61:76-83. [DOI: 10.1111/j.1574-695x.2010.00750.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
134 Rocha GA, Rocha AM, Gomes AD, Faria CL Jr, Melo FF, Batista SA, Fernandes VC, Almeida NB, Teixeira KN, Brito KS, Queiroz DM. STAT3 polymorphism and Helicobacter pylori CagA strains with higher number of EPIYA-C segments independently increase the risk of gastric cancer. BMC Cancer. 2015;15:528. [PMID: 26186918 DOI: 10.1186/s12885-015-1533-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
135 Wang MY, Chen C, Gao XZ, Li J, Yue J, Ling F, Wang XC, Shao SH. Distribution of Helicobacter pylori virulence markers in patients with gastroduodenal diseases in a region at high risk of gastric cancer. Microb Pathog. 2013;59-60:13-18. [PMID: 23583809 DOI: 10.1016/j.micpath.2013.04.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
136 Cheok YY, Lee CYQ, Cheong HC, Vadivelu J, Looi CY, Abdullah S, Wong WF. An Overview of Helicobacter pylori Survival Tactics in the Hostile Human Stomach Environment. Microorganisms 2021;9:2502. [PMID: 34946105 DOI: 10.3390/microorganisms9122502] [Reference Citation Analysis]
137 Ponzetto A, Holton J, Vaira D. Letter: years of life that could be saved by preventing HCC. Aliment Pharmacol Ther 2017;45:375-6. [PMID: 27933689 DOI: 10.1111/apt.13853] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
138 Nguewa PA, Villa TG, Notario V. Microbiome Control in the Prevention and Early Management of Cancer. In: Villa TG, Vinas M, editors. New Weapons to Control Bacterial Growth. Cham: Springer International Publishing; 2016. pp. 219-37. [DOI: 10.1007/978-3-319-28368-5_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
139 Nagini S. Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol 2012; 4(7): 156-169 [PMID: 22844547 DOI: 10.4251/wjgo.v4.i7.156] [Cited by in CrossRef: 256] [Cited by in F6Publishing: 232] [Article Influence: 25.6] [Reference Citation Analysis]
140 Lim MCC, Maubach G, Sokolova O, Feige MH, Diezko R, Buchbinder J, Backert S, Schlüter D, Lavrik IN, Naumann M. Pathogen-induced ubiquitin-editing enzyme A20 bifunctionally shuts off NF-κB and caspase-8-dependent apoptotic cell death. Cell Death Differ 2017;24:1621-31. [PMID: 28574503 DOI: 10.1038/cdd.2017.89] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
141 Hammond CE, Beeson C, Suarez G, Peek RM Jr, Backert S, Smolka AJ. Helicobacter pylori virulence factors affecting gastric proton pump expression and acid secretion. Am J Physiol Gastrointest Liver Physiol 2015;309:G193-201. [PMID: 26045613 DOI: 10.1152/ajpgi.00099.2015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
142 Valenzuela MA, Canales J, Corvalán AH, Quest AF. Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis. World J Gastroenterol 2015; 21(45): 12742-12756 [PMID: 26668499 DOI: 10.3748/wjg.v21.i45.12742] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 49] [Article Influence: 8.0] [Reference Citation Analysis]
143 Soutto M, Romero-Gallo J, Krishna U, Piazuelo MB, Washington MK, Belkhiri A, Peek RM Jr, El-Rifai W. Loss of TFF1 promotes Helicobacter pylori-induced β-catenin activation and gastric tumorigenesis. Oncotarget 2015;6:17911-22. [PMID: 25980439 DOI: 10.18632/oncotarget.3772] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
144 Hayashi T, Senda M, Morohashi H, Higashi H, Horio M, Kashiba Y, Nagase L, Sasaya D, Shimizu T, Venugopalan N, Kumeta H, Noda NN, Inagaki F, Senda T, Hatakeyama M. Tertiary structure-function analysis reveals the pathogenic signaling potentiation mechanism of Helicobacter pylori oncogenic effector CagA. Cell Host Microbe. 2012;12:20-33. [PMID: 22817985 DOI: 10.1016/j.chom.2012.05.010] [Cited by in Crossref: 105] [Cited by in F6Publishing: 93] [Article Influence: 11.7] [Reference Citation Analysis]
145 Wu J, Li W, Zheng Z, Lu X, Zhang H, Ma Y, Wang R. Design, synthesis, biological evaluation, common feature pharmacophore model and molecular dynamics simulation studies of ethyl 4-(phenoxymethyl)-2-phenylthiazole-5-carboxylate as Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors. J Biomol Struct Dyn 2021;39:1174-88. [PMID: 32036779 DOI: 10.1080/07391102.2020.1726817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Johnson SM, Evers BM. Translational research in gastric malignancy. Surg Oncol Clin N Am 2008;17:323-40, viii. [PMID: 18375355 DOI: 10.1016/j.soc.2008.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
147 Roesler BM, Rabelo-Gonçalves EM, Zeitune JM. Virulence Factors of Helicobacter pylori: A Review. Clin Med Insights Gastroenterol 2014;7:9-17. [PMID: 24833944 DOI: 10.4137/CGast.S13760] [Cited by in Crossref: 72] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
148 Tseng PC, Huang WC, Chen CL, Sheu BS, Shan YS, Tsai CC, Wang CY, Chen SO, Hsieh CY, Lin CF. Regulation of SHP2 by PTEN/AKT/GSK-3β signaling facilitates IFN-γ resistance in hyperproliferating gastric cancer. Immunobiology. 2012;217:926-934. [PMID: 22325465 DOI: 10.1016/j.imbio.2012.01.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
149 Lv G, Zhu H, Zhou F, Lin Z, Lin G, Li C. AMP-activated protein kinase activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis. Biochem Biophys Res Commun 2014;453:13-8. [PMID: 25229685 DOI: 10.1016/j.bbrc.2014.09.028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
150 Sgouras DN, Panayotopoulou EG, Papadakos K, Martinez-Gonzalez B, Roumbani A, Panayiotou J, vanVliet-Constantinidou C, Mentis AF, Roma-Giannikou E. CagA and VacA polymorphisms do not correlate with severity of histopathological lesions in Helicobacter pylori-infected Greek children. J Clin Microbiol 2009;47:2426-34. [PMID: 19535517 DOI: 10.1128/JCM.00159-09] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
151 Waskito LA, Yih-Wu J, Yamaoka Y. The role of integrating conjugative elements in Helicobacter pylori: a review. J Biomed Sci 2018;25:86. [PMID: 30497458 DOI: 10.1186/s12929-018-0489-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
152 Matsunari O, Miftahussurur M, Shiota S, Suzuki R, Vilaichone RK, Uchida T, Ratanachu-ek T, Tshering L, Mahachai V, Yamaoka Y. Rare Helicobacter pylori Virulence Genotypes in Bhutan. Sci Rep 2016;6:22584. [PMID: 26931643 DOI: 10.1038/srep22584] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
153 Chen Y, Sheppard D, Dong X, Hu X, Chen M, Chen R, Chakrabarti J, Zavros Y, Peek RM, Chen LF. H. pylori infection confers resistance to apoptosis via Brd4-dependent BIRC3 eRNA synthesis. Cell Death Dis 2020;11:667. [PMID: 32820150 DOI: 10.1038/s41419-020-02894-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
154 Park JY, Forman D, Waskito LA, Yamaoka Y, Crabtree JE. Epidemiology of Helicobacter pylori and CagA-Positive Infections and Global Variations in Gastric Cancer. Toxins (Basel). 2018;10:pii: E163. [PMID: 29671784 DOI: 10.3390/toxins10040163] [Cited by in Crossref: 57] [Cited by in F6Publishing: 42] [Article Influence: 14.3] [Reference Citation Analysis]
155 Ebnet K. Organization of multiprotein complexes at cell-cell junctions. Histochem Cell Biol 2008;130:1-20. [PMID: 18365233 DOI: 10.1007/s00418-008-0418-7] [Cited by in Crossref: 113] [Cited by in F6Publishing: 110] [Article Influence: 8.1] [Reference Citation Analysis]
156 Elsalem L, Jum'ah AA, Alfaqih MA, Aloudat O. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives. Clin Exp Gastroenterol 2020;13:151-85. [PMID: 32440192 DOI: 10.2147/CEG.S243337] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
157 Ayada K, Yokota K, Kawahara Y, Yamamoto Y, Hirai K, Inaba T, Kita M, Okada H, Yamamoto K, Oguma K. Immune reactions against elongation factor 2 kinase: specific pathogenesis of gastric ulcer from Helicobacter pylori infection. Clin Dev Immunol 2009;2009:850623. [PMID: 19636416 DOI: 10.1155/2009/850623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
158 Guang W, Twaddell WS, Lillehoj EP. Molecular Interactions between MUC1 Epithelial Mucin, β-Catenin, and CagA Proteins. Front Immunol. 2012;3:105. [PMID: 22566976 DOI: 10.3389/fimmu.2012.00105] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
159 Bornschein J, Malfertheiner P. Gastric carcinogenesis. Langenbecks Arch Surg. 2011;396:729-742. [PMID: 21611816 DOI: 10.1007/s00423-011-0810-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
160 Hatakeyama M. Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell Host Microbe. 2014;15:306-316. [PMID: 24629337 DOI: 10.1016/j.chom.2014.02.008] [Cited by in Crossref: 251] [Cited by in F6Publishing: 219] [Article Influence: 31.4] [Reference Citation Analysis]
161 Bacigalupo ML, Carabias P, Troncoso MF. Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression. World J Gastroenterol 2017; 23(29): 5266-5281 [PMID: 28839427 DOI: 10.3748/wjg.v23.i29.5266] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
162 Hauck CR. Microbiology: preparing the shot. Nature 2007;449:798-9. [PMID: 17943113 DOI: 10.1038/449798a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
163 Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19:449-490. [PMID: 16847081 DOI: 10.1128/cmr.00054-05] [Cited by in Crossref: 1188] [Cited by in F6Publishing: 628] [Article Influence: 74.3] [Reference Citation Analysis]
164 Niller HH, Minarovits J. Epigenetics and Human Infectious Diseases. Epigenetics in Human Disease. Elsevier; 2012. pp. 415-41. [DOI: 10.1016/b978-0-12-388415-2.00021-4] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
165 Batista SA, Rocha GA, Rocha AM, Saraiva IE, Cabral MM, Oliveira RC, Queiroz DM. Higher number of Helicobacter pylori CagA EPIYA C phosphorylation sites increases the risk of gastric cancer, but not duodenal ulcer. BMC Microbiol. 2011;11:61. [PMID: 21435255 DOI: 10.1186/1471-2180-11-61] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 5.8] [Reference Citation Analysis]
166 Zhang BG, Hu L, Zang MD, Wang HX, Zhao W, Li JF, Su LP, Shao Z, Zhao X, Zhu ZG, Yan M, Liu B. Helicobacter pylori CagA induces tumor suppressor gene hypermethylation by upregulating DNMT1 via AKT-NFκB pathway in gastric cancer development. Oncotarget 2016;7:9788-800. [PMID: 26848521 DOI: 10.18632/oncotarget.7125] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 6.5] [Reference Citation Analysis]
167 An B, Lee G, Lim K, Moon BS, Kim JB. Identification of the repeated number of C and D regions of tyrosine phosphorylation motifs in Helicobacter pylori cagA using multiplex PCR. Microbiol Immunol 2008;52:479-83. [PMID: 18822081 DOI: 10.1111/j.1348-0421.2008.00064.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
168 Loh JT, Shaffer CL, Piazuelo MB, Bravo LE, McClain MS, Correa P, Cover TL. Analysis of cagA in Helicobacter pylori strains from Colombian populations with contrasting gastric cancer risk reveals a biomarker for disease severity. Cancer Epidemiol Biomarkers Prev 2011;20:2237-49. [PMID: 21859954 DOI: 10.1158/1055-9965.EPI-11-0548] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
169 Kumar N, Albert MJ, Al Abkal H, Siddique I, Ahmed N. What constitutes an Arabian Helicobacter pylori? Lessons from comparative genomics. Helicobacter. 2017;22. [PMID: 27277215 DOI: 10.1111/hel.12323] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
170 Jones KR, Whitmire JM, Merrell DS. A Tale of Two Toxins: Helicobacter Pylori CagA and VacA Modulate Host Pathways that Impact Disease. Front Microbiol. 2010;1:115. [PMID: 21687723 DOI: 10.3389/fmicb.2010.00115] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 7.6] [Reference Citation Analysis]
171 Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek RM, Azuma T. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene. 2007;26:4617-4626. [PMID: 17237808 DOI: 10.1038/sj.onc.1210251] [Cited by in Crossref: 298] [Cited by in F6Publishing: 292] [Article Influence: 19.9] [Reference Citation Analysis]
172 Takahashi-kanemitsu A, Knight CT, Hatakeyama M. Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis. Cell Mol Immunol 2020;17:50-63. [DOI: 10.1038/s41423-019-0339-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 12.3] [Reference Citation Analysis]
173 Lee KH, Kim JY, Kim WK, Shin DH, Choi KU, Kim DW, Lee WJ, Choi JH, Lee SH, Kim GH. Protective effect of rebamipide against Helicobacter pylori-CagA-induced effects on gastric epithelial cells. Dig Dis Sci. 2011;56:441-448. [PMID: 20556513 DOI: 10.1007/s10620-010-1299-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
174 Mbulaiteye SM. Helicobacter Pylori associated global gastric cancer burden. Front Biosci 2009;Volume:1490. [DOI: 10.2741/3320] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
175 Qiao Y, Li T, Zheng S, Wang H. The Hippo pathway as a drug target in gastric cancer. Cancer Lett 2018;420:14-25. [PMID: 29408652 DOI: 10.1016/j.canlet.2018.01.062] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
176 Lee MH, Yang JY, Cho Y, Woo HJ, Kwon HJ, Kim DH, Park M, Moon C, Yeon MJ, Kim HW, Seo WD, Kim SH, Kim JB. Inhibitory Effects of Menadione on Helicobacter pylori Growth and Helicobacter pylori-Induced Inflammation via NF-κB Inhibition. Int J Mol Sci 2019;20:E1169. [PMID: 30866458 DOI: 10.3390/ijms20051169] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
177 Naito Y, Ito M, Watanabe T, Suzuki H. Biomarkers in patients with gastric inflammation: a systematic review. Digestion. 2005;72:164-180. [PMID: 16179785 DOI: 10.1159/000088396] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
178 Park JS, Jun JS, Ryu EY, Yeom JS, Park ES, Seo JH, Lim JY, Park CH, Woo HO, Baik SC, Lee WK, Cho MJ, Rhee KH, Youn HS. Changes in Seroprevalence of Helicobacter pylori Infection over 20 Years in Jinju, Korea, from Newborns to the Elderly. J Korean Med Sci 2020;35:e259. [PMID: 32808510 DOI: 10.3346/jkms.2020.35.e259] [Reference Citation Analysis]
179 Shiota S, Matsunari O, Watada M, Yamaoka Y. Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiol. 2010;5:1885-1893. [PMID: 21155667 DOI: 10.2217/fmb.10.135] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
180 Xiao D, Zhang H, He L, Peng X, Wang Y, Xue G, Su P, Zhang J. High natural variability bacteria identification and typing: Helicobacter pylori analysis based on peptide mass fingerprinting. Journal of Proteomics 2014;98:112-22. [DOI: 10.1016/j.jprot.2013.11.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
181 Tsuji S, Tsujii M, Murata H, Nishida T, Komori M, Yasumaru M, Ishii S, Sasayama Y, Kawano S, Hayashi N. Helicobacter pylori eradication to prevent gastric cancer: Underlying molecular and cellular mechanisms. World J Gastroenterol 2006; 12(11): 1671-1680 [PMID: 16586533 DOI: 10.3748/wjg.v12.i11.1671] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
182 Choi RS, Lai WYX, Lee LTC, Wong WLC, Pei XM, Tsang HF, Leung JJ, Cho WCS, Chu MKM, Wong EYL, Wong SCC. Current and future molecular diagnostics of gastric cancer. Expert Rev Mol Diagn 2019;19:863-74. [PMID: 31448971 DOI: 10.1080/14737159.2019.1660645] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
183 Lai YP, Yang JC, Lin TZ, Lin JT, Wang JT. Helicobacter pylori infection and CagA protein translocation in human primary gastric epithelial cell culture. Helicobacter. 2006;11:451-459. [PMID: 16961808 DOI: 10.1111/j.1523-5378.2006.00438.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
184 Cover TL. Role of Helicobacter pylori CagL in modulating gastrin expression. Gut. 2012;61:965-966. [PMID: 22406936 DOI: 10.1136/gutjnl-2012-302142] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
185 Chan G, Kalaitzidis D, Neel BG. The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev. 2008;27:179-192. [PMID: 18286234 DOI: 10.1007/s10555-008-9126-y] [Cited by in Crossref: 248] [Cited by in F6Publishing: 241] [Article Influence: 17.7] [Reference Citation Analysis]
186 Imai S, Ooki T, Murata-Kamiya N, Komura D, Tahmina K, Wu W, Takahashi-Kanemitsu A, Knight CT, Kunita A, Suzuki N, Del Valle AA, Tsuboi M, Hata M, Hayakawa Y, Ohnishi N, Ueda K, Fukayama M, Ushiku T, Ishikawa S, Hatakeyama M. Helicobacter pylori CagA elicits BRCAness to induce genome instability that may underlie bacterial gastric carcinogenesis. Cell Host Microbe 2021;29:941-958.e10. [PMID: 33989515 DOI: 10.1016/j.chom.2021.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
187 Egi Y, Kim S, Ito M, Tanaka S, Yoshihara M, Haruma K, Chayama K. Helicobacter pylori infection is the major risk factor for gastric inflammation in the cardia. Dig Dis Sci 2006;51:1582-8. [PMID: 16602036 DOI: 10.1007/s10620-005-9046-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
188 Shafaie E, Saberi S, Esmaeili M, Karimi Z, Najafi S, Tashakoripoor M, Abdirad A, Hosseini ME, Mohagheghi MA, Khalaj V, Mohammadi M. Multiplex serology of Helicobacter pylori antigens in detection of current infection and atrophic gastritis - A simple and cost-efficient method. Microbial Pathogenesis 2018;119:137-44. [DOI: 10.1016/j.micpath.2018.04.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
189 Bernardini G, Figura N, Ponzetto A, Marzocchi B, Santucci A. Application of proteomics to the study of Helicobacter pylori and implications for the clinic. Expert Rev Proteomics 2017;14:477-90. [PMID: 28513226 DOI: 10.1080/14789450.2017.1331739] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
190 Giraud AS, Menheniott TR, Judd LM. Targeting STAT3 in gastric cancer. Expert Opin Ther Targets. 2012;16:889-901. [PMID: 22834702 DOI: 10.1517/14728222.2012.709238] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
191 Takata S, Ito M, Wada Y, Yoshihara M, Tanaka S, Chayama K. Pathogenetic role of the tyrosine-phosphorylated CagA EPIYA sequence of Helicobacter pylori in histological gastritis in Japanese patients. J Gastroenterol 2009;44:405-11. [DOI: 10.1007/s00535-009-0015-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
192 Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 2006;9:245-53. [DOI: 10.1007/s10120-006-0397-0] [Cited by in Crossref: 161] [Cited by in F6Publishing: 159] [Article Influence: 10.1] [Reference Citation Analysis]
193 Lin L, Chen J, Richardson JA, Parada LF. Mice lacking neurofibromin develop gastric hyperplasia. Am J Physiol Gastrointest Liver Physiol 2009;297:G751-61. [PMID: 19661150 DOI: 10.1152/ajpgi.00007.2009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
194 Maixner F, Krause-Kyora B, Turaev D, Herbig A, Hoopmann MR, Hallows JL, Kusebauch U, Vigl EE, Malfertheiner P, Megraud F, O'Sullivan N, Cipollini G, Coia V, Samadelli M, Engstrand L, Linz B, Moritz RL, Grimm R, Krause J, Nebel A, Moodley Y, Rattei T, Zink A. The 5300-year-old Helicobacter pylori genome of the Iceman. Science. 2016;351:162-165. [PMID: 26744403 DOI: 10.1126/science.aad2545] [Cited by in Crossref: 143] [Cited by in F6Publishing: 103] [Article Influence: 23.8] [Reference Citation Analysis]
195 Fowler M, Thomas RJ, Atherton J, Roberts IS, High NJ. Galectin-3 binds to Helicobacter pylori O-antigen: it is upregulated and rapidly secreted by gastric epithelial cells in response to H. pylori adhesion. Cell Microbiol 2006;8:44-54. [PMID: 16367865 DOI: 10.1111/j.1462-5822.2005.00599.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 4.9] [Reference Citation Analysis]
196 Yadegar A, Alebouyeh M, Zali MR. Analysis of the intactness of Helicobacter pylori cag pathogenicity island in Iranian strains by a new PCR-based strategy and its relationship with virulence genotypes and EPIYA motifs. Infect Genet Evol 2015;35:19-26. [PMID: 26205689 DOI: 10.1016/j.meegid.2015.07.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
197 Königer V, Holsten L, Harrison U, Busch B, Loell E, Zhao Q, Bonsor DA, Roth A, Kengmo-Tchoupa A, Smith SI, Mueller S, Sundberg EJ, Zimmermann W, Fischer W, Hauck CR, Haas R. Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA. Nat Microbiol 2016;2:16188. [PMID: 27748756 DOI: 10.1038/nmicrobiol.2016.188] [Cited by in Crossref: 83] [Cited by in F6Publishing: 80] [Article Influence: 13.8] [Reference Citation Analysis]
198 Kawai S, Goto Y, Ito LS, Oba-shinjo SM, Uno M, Shinjo SK, Marie SK, Ishida Y, Nishio K, Naito M, Hamajima N. Significant association between PTPN11 polymorphism and gastric atrophy among Japanese Brazilians. Gastric Cancer 2006;9:277-83. [DOI: 10.1007/s10120-006-0391-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
199 Yang JJ, Cho LY, Ko KP, Shin A, Ma SH, Choi BY, Han DS, Song KS, Kim YS, Lee JY. Genetic susceptibility on CagA-interacting molecules and gene-environment interaction with phytoestrogens: a putative risk factor for gastric cancer. PLoS One. 2012;7:e31020. [PMID: 22383989 DOI: 10.1371/journal.pone.0031020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
200 Lina TT, Gonzalez J, Pinchuk IV, Beswick EJ, Reyes VE. Helicobacter pylori elicits B7H3 expression on gastric epithelial cells: Implications in local T cell regulation and subset development during infection. Clin Oncol Res 2019;2. [PMID: 31998864 DOI: 10.31487/j.cor.2019.05.05] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
201 Arima K, Komohara Y, Bu L, Tsukamoto M, Itoyama R, Miyake K, Uchihara T, Ogata Y, Nakagawa S, Okabe H, Imai K, Hashimoto D, Chikamoto A, Yamashita YI, Baba H, Ishimoto T. Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer. Cancer Sci 2018;109:462-70. [PMID: 29224225 DOI: 10.1111/cas.13467] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
202 Shen D, Chen W, Zhu J, Wu G, Shen R, Xi M, Sun H. Therapeutic potential of targeting SHP2 in human developmental disorders and cancers. Eur J Med Chem 2020;190:112117. [PMID: 32061959 DOI: 10.1016/j.ejmech.2020.112117] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
203 Enomoto S, Yanaoka K, Utsunomiya H, Niwa T, Inada K, Deguchi H, Ueda K, Mukoubayashi C, Inoue I, Maekita T, Nakazawa K, Iguchi M, Arii K, Tamai H, Yoshimura N, Fujishiro M, Oka M, Ichinose M. Inhibitory effects of Japanese apricot (Prunus mume Siebold et Zucc.; Ume) on Helicobacter pylori-related chronic gastritis. Eur J Clin Nutr 2010;64:714-9. [DOI: 10.1038/ejcn.2010.70] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
204 Bourzac KM, Guillemin K. Helicobacter pylori-host cell interactions mediated by type IV secretion. Cell Microbiol. 2005;7:911-919. [PMID: 15953024 DOI: 10.1111/j.1462-5822.2005.00541.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 4.5] [Reference Citation Analysis]
205 Ahmed N, Majeed AA, Ahmed I, Hussain MA, Alvi A, Devi SM, Rizwan M, Ranjan A, Sechi LA, Mégraud F. genoBASE pylori: A genotype search tool and database of the human gastric pathogen Helicobacter pylori. Infection, Genetics and Evolution 2007;7:463-8. [DOI: 10.1016/j.meegid.2007.01.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
206 Bertout J, Thomas-tikhonenko A. Infection & Neoplastic Growth 101. In: Dalgleish AG, Haefner B, editors. The Link Between Inflammation and Cancer. Boston: Springer US; 2006. pp. 167-97. [DOI: 10.1007/0-387-26283-0_8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
207 Angelini A, Tosi T, Mas P, Acajjaoui S, Zanotti G, Terradot L, Hart DJ. Expression of Helicobacter pylori CagA domains by library-based construct screening: Expression of Helicobacter pylori CagA domains. FEBS Journal 2009;276:816-24. [DOI: 10.1111/j.1742-4658.2008.06826.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
208 Tripathi RKP, Ayyannan SR. Emerging chemical scaffolds with potential SHP2 phosphatase inhibitory capabilities - A comprehensive review. Chem Biol Drug Des 2021;97:721-73. [PMID: 33191603 DOI: 10.1111/cbdd.13807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
209 Kuzuhara T, Suganuma M, Kurusu M, Fujiki H. Helicobacter pylori-secreting protein Tipalpha is a potent inducer of chemokine gene expressions in stomach cancer cells. J Cancer Res Clin Oncol. 2007;133:287-296. [PMID: 17393199 DOI: 10.1007/s00432-006-0169-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
210 Zhang X, He Y, Liu S, Yu Z, Jiang ZX, Yang Z, Dong Y, Nabinger SC, Wu L, Gunawan AM, Wang L, Chan RJ, Zhang ZY. Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2). J Med Chem 2010;53:2482-93. [PMID: 20170098 DOI: 10.1021/jm901645u] [Cited by in Crossref: 127] [Cited by in F6Publishing: 120] [Article Influence: 10.6] [Reference Citation Analysis]
211 Cover TL, Lacy DB, Ohi MD. The Helicobacter pylori Cag Type IV Secretion System. Trends Microbiol 2020;28:682-95. [PMID: 32451226 DOI: 10.1016/j.tim.2020.02.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
212 Kaplan-Türköz B, Jiménez-Soto LF, Dian C, Ertl C, Remaut H, Louche A, Tosi T, Haas R, Terradot L. Structural insights into Helicobacter pylori oncoprotein CagA interaction with β1 integrin. Proc Natl Acad Sci USA. 2012;109:14640-14645. [PMID: 22908298 DOI: 10.1073/pnas.1206098109] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 9.1] [Reference Citation Analysis]
213 Papadakos KS, Sougleri IS, Mentis AF, Hatziloukas E, Sgouras DN. Presence of terminal EPIYA phosphorylation motifs in Helicobacter pylori CagA contributes to IL-8 secretion, irrespective of the number of repeats. PLoS One 2013;8:e56291. [PMID: 23409168 DOI: 10.1371/journal.pone.0056291] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
214 Andrzejewska J, Lee SK, Olbermann P, Lotzing N, Katzowitsch E, Linz B, Achtman M, Kado CI, Suerbaum S, Josenhans C. Characterization of the pilin ortholog of the Helicobacter pylori type IV cag pathogenicity apparatus, a surface-associated protein expressed during infection. J Bacteriol. 2006;188:5865-5877. [PMID: 16885455 DOI: 10.1128/jb.00060-06] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
215 Handa O, Naito Y, Yoshikawa T. CagA protein of Helicobacter pylori: a hijacker of gastric epithelial cell signaling. Biochem Pharmacol. 2007;73:1697-1702. [PMID: 17134680 DOI: 10.1016/j.bcp.2006.10.022] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 4.4] [Reference Citation Analysis]
216 Morgan RN, Saleh SE, Farrag HA, Aboulwafa MM. Bacterial cyclomodulins: types and roles in carcinogenesis. Crit Rev Microbiol 2021;:1-25. [PMID: 34265231 DOI: 10.1080/1040841X.2021.1944052] [Reference Citation Analysis]
217 Duncan SS, Valk PL, McClain MS, Shaffer CL, Metcalf JA, Bordenstein SR, Cover TL. Comparative genomic analysis of East Asian and non-Asian Helicobacter pylori strains identifies rapidly evolving genes. PLoS One. 2013;8:e55120. [PMID: 23383074 DOI: 10.1371/journal.pone.0055120] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
218 Uchida T, Kanada R, Tsukamoto Y, Hijiya N, Matsuura K, Yano S, Yokoyama S, Kishida T, Kodama M, Murakami K. Immunohistochemical diagnosis of the cagA-gene genotype of Helicobacter pylori with anti-East Asian CagA-specific antibody. Cancer Sci. 2007;98:521-528. [PMID: 17284255 DOI: 10.1111/j.1349-7006.2007.00415.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 3.7] [Reference Citation Analysis]
219 Zhang J, Sun X, Wang J, Zhang F, Li X, Han J. Association of the IL-1RN variable number of tandem repeat polymorphism and Helicobacter pylori infection: A meta-analysis. PLoS One 2017;12:e0175052. [PMID: 28384207 DOI: 10.1371/journal.pone.0175052] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
220 Murphy G, Freedman ND, Michel A, Fan JH, Taylor PR, Pawlita M, Qiao YL, Zhang H, Yu K, Abnet CC, Dawsey SM. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort. Int J Cancer 2015;137:1938-46. [PMID: 25845708 DOI: 10.1002/ijc.29543] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
221 Gaddy JA, Radin JN, Loh JT, Zhang F, Washington MK, Peek RM, Algood HM, Cover TL. High dietary salt intake exacerbates Helicobacter pylori-induced gastric carcinogenesis. Infect Immun. 2013;81:2258-2267. [PMID: 23569116 DOI: 10.1128/iai.01271-12] [Cited by in Crossref: 99] [Cited by in F6Publishing: 76] [Article Influence: 11.0] [Reference Citation Analysis]
222 Ju H, Lim B, Kim M, Kim YS, Kim WH, Ihm C, Noh SM, Han DS, Yu HJ, Choi BY, Kang C. A regulatory polymorphism at position -309 in PTPRCAP is associated with susceptibility to diffuse-type gastric cancer and gene expression. Neoplasia 2009;11:1340-7. [PMID: 20019842 DOI: 10.1593/neo.91132] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
223 Takamura A, Ito M, Imagawa S, Takata S, Tanaka S, Teixeira CR, Kamada T, Haruma K, Chayama K. Helicobacter pylori cagA polymorphism and gastric inflammation: an international comparison between Japanese and Brazilian patients. Scand J Gastroenterol. 2011;46:1051-1056. [PMID: 21736532 DOI: 10.3109/00365521.2011.598549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
224 Prinz C, Schwendy S, Voland P. H pylori and gastric cancer: Shifting the global burden. World J Gastroenterol 2006; 12(34): 5458-5464 [PMID: 17006981 DOI: 10.3748/wjg.v12.i34.5458] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
225 Christie PJ, Atmakuri K, Krishnamoorthy V, Jakubowski S, Cascales E. Biogenesis, architecture, and function of bacterial type IV secretion systems. Annu Rev Microbiol 2005;59:451-85. [PMID: 16153176 DOI: 10.1146/annurev.micro.58.030603.123630] [Cited by in Crossref: 461] [Cited by in F6Publishing: 427] [Article Influence: 28.8] [Reference Citation Analysis]
226 Saju P, Murata-Kamiya N, Hayashi T, Senda Y, Nagase L, Noda S, Matsusaka K, Funata S, Kunita A, Urabe M, Seto Y, Fukayama M, Kaneda A, Hatakeyama M. Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus. Nat Microbiol. 2016;1:16026. [PMID: 27572445 DOI: 10.1038/nmicrobiol.2016.26] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
227 Xia Y, Yamaoka Y, Zhu Q, Matha I, Gao X. A comprehensive sequence and disease correlation analyses for the C-terminal region of CagA protein of Helicobacter pylori. PLoS One. 2009;4:e7736. [PMID: 19893742 DOI: 10.1371/journal.pone.0007736] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 5.8] [Reference Citation Analysis]
228 Usui G, Sato H, Shinozaki T, Jinno T, Fujibayashi K, Ishii K, Horiuchi H, Morikawa T, Gunji T, Matsuhashi N. Association Between Helicobacter pylori Infection and Short-segment/Long-segment Barrett's Esophagus in a Japanese Population: A Large Cross-Sectional Study. J Clin Gastroenterol 2020;54:439-44. [PMID: 31524650 DOI: 10.1097/MCG.0000000000001264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
229 Poppe M, Feller SM, Römer G, Wessler S. Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility. Oncogene 2007;26:3462-72. [DOI: 10.1038/sj.onc.1210139] [Cited by in Crossref: 132] [Cited by in F6Publishing: 130] [Article Influence: 8.3] [Reference Citation Analysis]
230 Repetto D, Aramu S, Boeri Erba E, Sharma N, Grasso S, Russo I, Jensen ON, Cabodi S, Turco E, Di Stefano P, Defilippi P. Mapping of p140Cap phosphorylation sites: the EPLYA and EGLYA motifs have a key role in tyrosine phosphorylation and Csk binding, and are substrates of the Abl kinase. PLoS One 2013;8:e54931. [PMID: 23383002 DOI: 10.1371/journal.pone.0054931] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
231 Matsuo Y, Shiota S, Matsunari O, Suzuki R, Watada M, Binh TT, Kinjo N, Kinjo F, Yamaoka Y. Helicobacter pylori cagA 12-bp insertion can be a marker for duodenal ulcer in Okinawa, Japan. J Gastroenterol Hepatol 2013;28:291-6. [PMID: 23190390 DOI: 10.1111/jgh.12067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
232 Song W, Anselmo AC, Huang L. Nanotechnology intervention of the microbiome for cancer therapy. Nat Nanotechnol 2019;14:1093-103. [DOI: 10.1038/s41565-019-0589-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 15.0] [Reference Citation Analysis]
233 Barr AJ. Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development. Future Med Chem 2010;2:1563-76. [PMID: 21426149 DOI: 10.4155/fmc.10.241] [Cited by in Crossref: 191] [Cited by in F6Publishing: 174] [Article Influence: 17.4] [Reference Citation Analysis]
234 Hatakeyama M. SagA of CagA in Helicobacter pylori pathogenesis. Curr Opin Microbiol. 2008;11:30-37. [PMID: 18243773 DOI: 10.1016/j.mib.2007.12.003] [Cited by in Crossref: 87] [Cited by in F6Publishing: 93] [Article Influence: 6.2] [Reference Citation Analysis]
235 Bhat N, Gaensbauer J, Peek RM, Bloch K, Tham KT, Blaser MJ, Perez-Perez G. Local and systemic immune and inflammatory responses to Helicobacter pylori strains. Clin Diagn Lab Immunol 2005;12:1393-400. [PMID: 16339062 DOI: 10.1128/CDLI.12.12.1393-1400.2005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
236 de Brito BB, da Silva FAF, de Melo FF. Role of polymorphisms in genes that encode cytokines and Helicobacter pylori virulence factors in gastric carcinogenesis. World J Clin Oncol 2018; 9(5): 83-89 [PMID: 30254963 DOI: 10.5306/wjco.v9.i5.83] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
237 Oosthuysen WF, Mueller T, Dittrich MT, Schubert-unkmeir A. Neisseria meningitidis causes cell cycle arrest of human brain microvascular endothelial cells at S phase via p21 and cyclin G2: N. meningitidis induces S phase arrest. Cell Microbiol 2016;18:46-65. [DOI: 10.1111/cmi.12482] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
238 Qian S, Golubnitschaja O, Zhan X. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles. EPMA J 2019;10:365-81. [PMID: 31832112 DOI: 10.1007/s13167-019-00194-x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 19.0] [Reference Citation Analysis]
239 Wroblewski LE, Peek RM Jr. Helicobacter pylori, Cancer, and the Gastric Microbiota. Adv Exp Med Biol. 2016;908:393-408. [PMID: 27573782 DOI: 10.1007/978-3-319-41388-4_19] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
240 Sekiguchi H, Irie K, Murakami A. Suppression of CD74 expression and Helicobacter pylori adhesion by auraptene targeting serum starvation-activated ERK1/2 in NCI-N87 gastric carcinoma cells. Biosci Biotechnol Biochem. 2010;74:1018-1024. [PMID: 20460732 DOI: 10.1271/bbb.90910] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
241 Senda Y, Murata-Kamiya N, Hatakeyama M. C-terminal Src kinase-mediated EPIYA phosphorylation of Pragmin creates a feed-forward C-terminal Src kinase activation loop that promotes cell motility. Cancer Sci 2016;107:972-80. [PMID: 27116701 DOI: 10.1111/cas.12962] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
242 Cover TL, Peek RM. Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut Microbes. 2013;4:482-493. [PMID: 23989802 DOI: 10.4161/gmic.26262] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 6.7] [Reference Citation Analysis]
243 Huang C, Chiou S. Proteomic analysis of upregulated proteins in Helicobacter pylori under oxidative stress induced by hydrogen peroxide. The Kaohsiung Journal of Medical Sciences 2011;27:544-53. [DOI: 10.1016/j.kjms.2011.06.019] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
244 Chen YH, Wang CL, Xie Y. Progress of research into the pathogenic mechanism of Helicobacter pylori and the preventive role of probiotics in H. pylori infection. Shijie Huaren Xiaohua Zazhi 2007; 15(25): 2690-2697 [DOI: 10.11569/wcjd.v15.i25.2690] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
245 Frazer I. Is vaccine therapy the future in cancer prevention? Expert Opin Pharmacother 2004;5:2427-34. [PMID: 15571460 DOI: 10.1517/14656566.5.12.2427] [Reference Citation Analysis]
246 Romano M, Ricci V, Zarrilli R. Mechanisms of Disease: Helicobacter pylori-related gastric carcinogenesis—implications for chemoprevention. Nat Rev Gastroenterol Hepatol 2006;3:622-32. [DOI: 10.1038/ncpgasthep0634] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
247 Kurashima Y, Murata-Kamiya N, Kikuchi K, Higashi H, Azuma T, Kondo S, Hatakeyama M. Deregulation of beta-catenin signal by Helicobacter pylori CagA requires the CagA-multimerization sequence. Int J Cancer 2008;122:823-31. [PMID: 17960618 DOI: 10.1002/ijc.23190] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
248 Scharf W, Schauer S, Freyburger F, Petrovec M, Schaarschmidt-Kiener D, Liebisch G, Runge M, Ganter M, Kehl A, Dumler JS, Garcia-Perez AL, Jensen J, Fingerle V, Meli ML, Ensser A, Stuen S, von Loewenich FD. Distinct host species correlate with Anaplasma phagocytophilum ankA gene clusters. J Clin Microbiol 2011;49:790-6. [PMID: 21177886 DOI: 10.1128/JCM.02051-10] [Cited by in Crossref: 102] [Cited by in F6Publishing: 62] [Article Influence: 8.5] [Reference Citation Analysis]
249 Busler VJ, Torres VJ, McClain MS, Tirado O, Friedman DB, Cover TL. Protein-protein interactions among Helicobacter pylori cag proteins. J Bacteriol 2006;188:4787-800. [PMID: 16788188 DOI: 10.1128/JB.00066-06] [Cited by in Crossref: 55] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
250 Ferreira Júnior M, Batista SA, Vidigal PV, Cordeiro AA, Oliveira FM, Prata LO, Diniz AE, Barral CM, Barbuto RC, Gomes AD. Infection with CagA-positive Helicobacter pylori strain containing three EPIYA C phosphorylation sites is associated with more severe gastric lesions in experimentally infected Mongolian gerbils (Meriones unguiculatus). Eur J Histochem. 2015;59:2489. [PMID: 26150158 DOI: 10.4081/ejh.2015.2489] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
251 Kamangar F, Qiao YL, Blaser MJ, Sun XD, Katki H, Fan JH, Perez-Perez GI, Abnet CC, Zhao P, Mark SD, Taylor PR, Dawsey SM. Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer. 2007;96:172-176. [PMID: 17179990 DOI: 10.1038/sj.bjc.6603517] [Cited by in Crossref: 94] [Cited by in F6Publishing: 97] [Article Influence: 5.9] [Reference Citation Analysis]
252 Ren S, Higashi H, Lu H, Azuma T, Hatakeyama M. Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells. J Biol Chem. 2006;281:32344-32352. [PMID: 16954210 DOI: 10.1074/jbc.m606172200] [Cited by in Crossref: 95] [Cited by in F6Publishing: 51] [Article Influence: 5.9] [Reference Citation Analysis]
253 Miyamoto D, Miyamoto M, Takahashi A, Yomogita Y, Higashi H, Kondo S, Hatakeyama M. Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors. Oncogene. 2008;27:3508-3515. [PMID: 18223690 DOI: 10.1038/sj.onc.1211019] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
254 Ouidir T, Jouenne T, Hardouin J. Post-translational modifications in Pseudomonas aeruginosa revolutionized by proteomic analysis. Biochimie 2016;125:66-74. [PMID: 26952777 DOI: 10.1016/j.biochi.2016.03.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
255 Tran LS, Chonwerawong M, Ferrero RL. Regulation and functions of inflammasome-mediated cytokines in Helicobacter pylori infection. Microbes Infect. 2017;19:449-458. [PMID: 28690082 DOI: 10.1016/j.micinf.2017.06.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
256 Lord AR, Simms LA, Hanigan K, Sullivan R, Hobson P, Radford-Smith GL. Protective effects of Helicobacter pylori for IBD are related to the cagA-positive strain. Gut. 2018;67:393-394. [PMID: 28408384 DOI: 10.1136/gutjnl-2017-313805] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
257 Park DW, Lee KJ, Jin SH, Lee JH, Min JS, Park SH, Yu HJ, Bang HY, Lee JI. Phenotypic Differences of Gastric Cancer according to the Helicobacter pylori Infection in Korean Patients. J Gastric Cancer 2010;10:168-74. [PMID: 22076182 DOI: 10.5230/jgc.2010.10.4.168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
258 Nougayrède JP, Taieb F, De Rycke J, Oswald E. Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol. 2005;13:103-110. [PMID: 15737728 DOI: 10.1016/j.tim.2005.01.002] [Cited by in Crossref: 143] [Cited by in F6Publishing: 143] [Article Influence: 8.4] [Reference Citation Analysis]
259 Ostman A, Hellberg C, Böhmer FD. Protein-tyrosine phosphatases and cancer. Nat Rev Cancer 2006;6:307-20. [PMID: 16557282 DOI: 10.1038/nrc1837] [Cited by in Crossref: 432] [Cited by in F6Publishing: 419] [Article Influence: 27.0] [Reference Citation Analysis]
260 Hayashi Y, Tsujii M, Wang J, Kondo J, Akasaka T, Jin Y, Li W, Nakamura T, Nishida T, Iijima H. CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis. Gut. 2013;62:1536-1546. [PMID: 22936674 DOI: 10.1136/gutjnl-2011-301625] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 8.0] [Reference Citation Analysis]
261 Vaziri F, Najar Peerayeh S, Alebouyeh M, Molaei M, Maghsoudi N, Zali MR. Determination of Helicobacter pylori CagA EPIYA types in Iranian isolates with different gastroduodenal disorders. Infect Genet Evol. 2013;17:101-105. [PMID: 23567822 DOI: 10.1016/j.meegid.2013.03.048] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
262 Qadri Q, Afroze D, Rasool R, Gulzar G, Naqash S, Siddiqi MA, Shah ZA. CagA subtyping in Helicobacter pylori isolates from gastric cancer patients in an ethnic Kashmiri population. Microbial Pathogenesis 2014;66:40-3. [DOI: 10.1016/j.micpath.2013.12.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
263 Kuo S, Yeh K, Chen L, Lin C, Hsu P, Wu M, Liou J, Tsai H, Tzeng Y, Cheng A. Helicobacter pylori CagA Translocation Is Closely Associated With the Expression of CagA-signaling Molecules in Low-grade Gastric Mucosa-associated Lymphoid Tissue Lymphoma. American Journal of Surgical Pathology 2015;39:761-6. [DOI: 10.1097/pas.0000000000000437] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
264 Duncan SS, Valk PL, Shaffer CL, Bordenstein SR, Cover TL. J-Western forms of Helicobacter pylori cagA constitute a distinct phylogenetic group with a widespread geographic distribution. J Bacteriol 2012;194:1593-604. [PMID: 22247512 DOI: 10.1128/JB.06340-11] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
265 Mendoza-elizalde S, Cortés-márquez A, Giono-cerezo S, Zuñiga G, Consuelo-sánchez A, Valencia-mayoral P, Vigueras-galindo J, Escalona-venegas G, Arellano-galindo J, Velázquez-guadarrama N. Analysis of the genotypic diversity of strains of Helicobacter pylori isolated from pediatric patients in Mexico. Infection, Genetics and Evolution 2015;29:68-74. [DOI: 10.1016/j.meegid.2014.11.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
266 Kamangar F, Dawsey SM, Blaser MJ, Perez-perez GI, Pietinen P, Newschaffer CJ, Abnet CC, Albanes D, Virtamo J, Taylor PR. Opposing Risks of Gastric Cardia and Noncardia Gastric Adenocarcinomas Associated With Helicobacter pylori Seropositivity. JNCI: Journal of the National Cancer Institute 2006;98:1445-52. [DOI: 10.1093/jnci/djj393] [Cited by in Crossref: 207] [Cited by in F6Publishing: 190] [Article Influence: 12.9] [Reference Citation Analysis]
267 Niller HH, Banati F, Ay E, Minarovits J. Microbe-Induced Epigenetic Alterations. In: Minarovits J, Niller HH, editors. Patho-Epigenetics of Disease. New York: Springer; 2012. pp. 419-55. [DOI: 10.1007/978-1-4614-3345-3_14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
268 Mane SP, Dominguez-Bello MG, Blaser MJ, Sobral BW, Hontecillas R, Skoneczka J, Mohapatra SK, Crasta OR, Evans C, Modise T, Shallom S, Shukla M, Varon C, Mégraud F, Maldonado-Contreras AL, Williams KP, Bassaganya-Riera J. Host-interactive genes in Amerindian Helicobacter pylori diverge from their Old World homologs and mediate inflammatory responses. J Bacteriol 2010;192:3078-92. [PMID: 20400544 DOI: 10.1128/JB.00063-10] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
269 Necchi V, Balduini A, Noris P, Barozzi S, Sommi P, di Buduo C, Balduini CL, Solcia E, Pecci A. Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. Thromb Haemost 2013;109:263-71. [PMID: 23223974 DOI: 10.1160/TH12-07-0497] [Cited by in Crossref: 39] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
270 Zhang Z, Huang Q, Tao X, Song G, Zheng P, Li H, Sun H, Xia W. The unique trimeric assembly of the virulence factor HtrA from Helicobacter pylori occurs via N-terminal domain swapping. J Biol Chem 2019;294:7990-8000. [PMID: 30936204 DOI: 10.1074/jbc.RA119.007387] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
271 Sommi P, Necchi V, Vitali A, Montagna D, De Luigi A, Salmona M, Ricci V, Solcia E. PaCS is a novel cytoplasmic structure containing functional proteasome and inducible by cytokines/trophic factors. PLoS One 2013;8:e82560. [PMID: 24358206 DOI: 10.1371/journal.pone.0082560] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
272 Tsugawa H, Mori H, Matsuzaki J, Sato A, Saito Y, Imoto M, Suematsu M, Suzuki H. CAPZA1 determines the risk of gastric carcinogenesis by inhibiting Helicobacter pylori CagA-degraded autophagy. Autophagy 2019;15:242-58. [PMID: 30176157 DOI: 10.1080/15548627.2018.1515530] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
273 Watada M, Shiota S, Matsunari O, Suzuki R, Murakami K, Fujioka T, Yamaoka Y. Association between Helicobacter pylori cagA-related genes and clinical outcomes in Colombia and Japan. BMC Gastroenterol. 2011;11:141. [PMID: 22189161 DOI: 10.1186/1471-230x-11-141] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
274 Binh TT, Tuan VP, Dung HDQ, Tung PH, Tri TD, Thuan NPM, Tam LQ, Nam BC, Giang DA, Hoan PQ, Uchida T, Trang TTH, Khien VV, Yamaoka Y. Molecular Epidemiology of Helicobacter pylori Infection in a Minor Ethnic Group of Vietnam: A Multiethnic, Population-Based Study. Int J Mol Sci 2018;19:E708. [PMID: 29494554 DOI: 10.3390/ijms19030708] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
275 Kang DW, Yang ES, Noh YN, Hwang WC, Jo SY, Suh YA, Park WS, Choi KY, Min DS. MicroRNA-320a and microRNA-4496 attenuate Helicobacter pylori cytotoxin-associated gene A (CagA)-induced cancer-initiating potential and chemoresistance by targeting β-catenin and ATP-binding cassette, subfamily G, member 2. J Pathol 2017;241:614-25. [PMID: 28008607 DOI: 10.1002/path.4866] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
276 Bridge DR, Merrell DS. Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease. Gut Microbes. 2013;4:101-117. [PMID: 23380646 DOI: 10.4161/gmic.23797] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
277 Schätzle S, Specht M, Waidner B. Coiled coil rich proteins (Ccrp) influence molecular pathogenicity of Helicobacter pylori. PLoS One 2015;10:e0121463. [PMID: 25822999 DOI: 10.1371/journal.pone.0121463] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
278 Goodman B, Gardner H. The microbiome and cancer. J Pathol. 2018;244:667-676. [PMID: 29377130 DOI: 10.1002/path.5047] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 19.0] [Reference Citation Analysis]
279 Shaffer CL, Good JA, Kumar S, Krishnan KS, Gaddy JA, Loh JT, Chappell J, Almqvist F, Cover TL, Hadjifrangiskou M. Peptidomimetic Small Molecules Disrupt Type IV Secretion System Activity in Diverse Bacterial Pathogens. mBio 2016;7:e00221-16. [PMID: 27118587 DOI: 10.1128/mBio.00221-16] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
280 Papadakos KS, Sougleri IS, Mentis AF, Sgouras DN. A Mutagenesis Method for the Addition and Deletion of Highly Repetitive DNA Regions: The Paradigm of EPIYA Motifs in the cagA Gene of Helicobacter pylori. Helicobacter 2013;18:229-41. [DOI: 10.1111/hel.12029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
281 Lamb A, Yang XD, Tsang YH, Li JD, Higashi H, Hatakeyama M, Peek RM, Blanke SR, Chen LF. Helicobacter pylori CagA activates NF-kappaB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination. EMBO Rep. 2009;10:1242-1249. [PMID: 19820695 DOI: 10.1038/embor.2009.210] [Cited by in Crossref: 118] [Cited by in F6Publishing: 123] [Article Influence: 9.1] [Reference Citation Analysis]
282 Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila). 2008;1:329-338. [PMID: 19138977 DOI: 10.1158/1940-6207.capr-08-0109] [Cited by in Crossref: 220] [Cited by in F6Publishing: 116] [Article Influence: 16.9] [Reference Citation Analysis]
283 Gangwer KA, Shaffer CL, Suerbaum S, Lacy DB, Cover TL, Bordenstein SR. Molecular evolution of the Helicobacter pylori vacuolating toxin gene vacA. J Bacteriol. 2010;192:6126-6135. [PMID: 20870762 DOI: 10.1128/jb.01081-10] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
284 Godlewska R, Dzwonek A, Mikuła M, Ostrowski J, Pawłowski M, Bujnicki JM, Jagusztyn-Krynicka EK. Helicobacter pylori protein oxidation influences the colonization process. Int J Med Microbiol 2006;296:321-4. [PMID: 16545604 DOI: 10.1016/j.ijmm.2005.11.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
285 Sierra R, Une C, Ramírez V, Alpízar-Alpízar W, González MI, Ramírez JA, Mascarel A, Cuenca P, Pérez-Pérez G, Mégraud F. Relation of atrophic gastritis with Helicobacter pylori-CagA+ and interleukin-1 gene polymorphisms. World J Gastroenterol 2008; 14(42): 6481-6487 [PMID: 19030199 DOI: 10.3748/wjg.14.6481] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
286 Chen Y, Segers S, Blaser MJ. Association between Helicobacter pylori and mortality in the NHANES III study. Gut. 2013;62:1262-1269. [PMID: 23303440 DOI: 10.1136/qutjnl-2012-303018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
287 Loh JT, Torres VJ, Algood HM, McClain MS, Cover TL. Helicobacter pylori HopQ outer membrane protein attenuates bacterial adherence to gastric epithelial cells. FEMS Microbiol Lett 2008;289:53-8. [PMID: 19065710 DOI: 10.1111/j.1574-6968.2008.01368.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
288 Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 1995;19 Suppl 1:S37-S43. [PMID: 7762738 DOI: 10.1007/s00535-009-0014-1] [Cited by in Crossref: 125] [Cited by in F6Publishing: 128] [Article Influence: 4.6] [Reference Citation Analysis]
289 Shiota S, Suzuki R, Yamaoka Y. The significance of virulence factors in Helicobacter pylori. J Dig Dis. 2013;14:341-349. [PMID: 23452293 DOI: 10.1111/1751-2980.12054] [Cited by in Crossref: 80] [Cited by in F6Publishing: 63] [Article Influence: 10.0] [Reference Citation Analysis]
290 Hatakeyama M. Anthropological and clinical implications for the structural diversity of the Helicobacter pylori CagA oncoprotein. Cancer Sci. 2011;102:36-43. [PMID: 20942897 DOI: 10.1111/j.1349-7006.2010.01743.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 4.8] [Reference Citation Analysis]
291 Hashi K, Murata-Kamiya N, Varon C, Mégraud F, Dominguez-Bello MG, Hatakeyama M. Natural variant of the Helicobacter pylori CagA oncoprotein that lost the ability to interact with PAR1. Cancer Sci 2014;105:245-51. [PMID: 24354359 DOI: 10.1111/cas.12342] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
292 Corbinais C, Mathieu A, Kortulewski T, Radicella JP, Marsin S. Following transforming DNA in Helicobacter pylori from uptake to expression: Visualising H. pylori transformation. Molecular Microbiology 2016;101:1039-53. [DOI: 10.1111/mmi.13440] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
293 Oswald E, Nougayrède JP, Taieb F, Sugai M. Bacterial toxins that modulate host cell-cycle progression. Curr Opin Microbiol. 2005;8:83-91. [PMID: 15694861 DOI: 10.1016/j.mib.2004.12.011] [Cited by in Crossref: 109] [Cited by in F6Publishing: 103] [Article Influence: 6.4] [Reference Citation Analysis]
294 Koganebuchi K, Kimura R. Biomedical and genetic characteristics of the Ryukyuans: demographic history, diseases and physical and physiological traits. Ann Hum Biol 2019;46:354-66. [PMID: 31116031 DOI: 10.1080/03014460.2019.1582699] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
295 Kang DW, Hwang WC, Park MH, Ko GH, Ha WS, Kim KS, Lee YC, Choi KY, Min DS. Rebamipide Abolishes Helicobacter Pylori CagA-induced Phospholipase D1 Expression via Inhibition of NFκB and Suppresses Invasion of Gastric Cancer Cells. Oncogene. 2012;32:3531-3542. [PMID: 22890316 DOI: 10.1038/onc.2012.358] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
296 Bergé C, Terradot L. Structural Insights into Helicobacter pylori Cag Protein Interactions with Host Cell Factors. Curr Top Microbiol Immunol 2017;400:129-47. [PMID: 28124152 DOI: 10.1007/978-3-319-50520-6_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
297 Nishizawa T, Suzuki H. Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy. Biomed Res Int. 2015;2015:794378. [PMID: 25945346 DOI: 10.1155/2015/794378] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
298 Yasui W, Sentani K, Motoshita J, Nakayama H. Molecular Pathobiology of Gastric Cancer. Scand J Surg 2006;95:225-31. [DOI: 10.1177/145749690609500403] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
299 Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y, Lu H, Ohnishi N, Azuma T, Suzuki A, Ohno S, Hatakeyama M. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature. 2007;447:330-333. [PMID: 17507984 DOI: 10.1038/nature05765] [Cited by in Crossref: 325] [Cited by in F6Publishing: 321] [Article Influence: 21.7] [Reference Citation Analysis]
300 Kuo S, Chen L, Lin C, Yeh K, Shun C, Tzeng Y, Liou J, Wu M, Hsu P, Cheng A. Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL. Blood 2017;129:188-98. [DOI: 10.1182/blood-2016-04-713719] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
301 Yokoyama K, Higashi H, Ishikawa S, Fujii Y, Kondo S, Kato H, Azuma T, Wada A, Hirayama T, Aburatani H, Hatakeyama M. Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. Proc Natl Acad Sci U S A 2005;102:9661-6. [PMID: 15980153 DOI: 10.1073/pnas.0502529102] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 5.8] [Reference Citation Analysis]
302 Peek RM Jr. Orchestration of aberrant epithelial signaling by Helicobacter pylori CagA. Sci STKE 2005;2005:pe14. [PMID: 15798102 DOI: 10.1126/stke.2772005pe14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 0.3] [Reference Citation Analysis]
303 Stasi R, Evangelista ML, Brunetti M, Bussa S, Maritati R, Gallo A, Turrini L, Taccogna S, Crescenzi A, Angelini F. Primary gastric plasmacytoma and Helicobacter pylori infection. J Clin Oncol. 2009;27:150-153. [PMID: 19047299 DOI: 10.1200/jco.2008.19.8341] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
304 Honarmand-jahromy S, Siavoshi F, Malekzadeh R, Sattari TN, Latifi-navid S. Multiple repeats of Helicobacter pylori CagA EPIYA-C phosphorylation sites predict risk of gastric ulcer in Iran. Microbial Pathogenesis 2015;89:87-92. [DOI: 10.1016/j.micpath.2015.09.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
305 Nagase L, Murata-Kamiya N, Hatakeyama M. Potentiation of Helicobacter pylori CagA protein virulence through homodimerization. J Biol Chem 2011;286:33622-31. [PMID: 21813645 DOI: 10.1074/jbc.M111.258673] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
306 Nie S, Chen T, Yang X, Huai P, Lu M. Association of Helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis: HP infection and esophageal cancer. Dis Esophagus 2014;27:645-53. [DOI: 10.1111/dote.12194] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 6.4] [Reference Citation Analysis]
307 Wu Y, Guo JF. Expression and purification of 15N-labeled 2-SH2 protein domain of SHP-2 from Homo sapiens in Escherichia coli for NMR studies and applications. Int J Biol Macromol 2009;45:1-7. [PMID: 19056419 DOI: 10.1016/j.ijbiomac.2008.10.013] [Reference Citation Analysis]
308 Hatakeyama M, Higashi H. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci. 2005;96:835-843. [PMID: 16367902 DOI: 10.1111/j.1349-7006.2005.00130.x] [Cited by in Crossref: 162] [Cited by in F6Publishing: 154] [Article Influence: 10.1] [Reference Citation Analysis]
309 Rojas-Rengifo DF, Alvarez-Silva MC, Ulloa-Guerrero CP, Nuñez-Velez VL, Del Pilar Delgado M, Aguilera SM, Castro H, Jaramillo CA, Fernando González Barrios A. Intramolecular energies of the cytotoxic protein CagA of Helicobacter pylori as a possible descriptor of strains' pathogenicity level. Comput Biol Chem 2018;76:17-22. [PMID: 29864542 DOI: 10.1016/j.compbiolchem.2018.05.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
310 Boulard O, Kirchberger S, Royston DJ, Maloy KJ, Powrie FM. Identification of a genetic locus controlling bacteria-driven colitis and associated cancer through effects on innate inflammation. J Exp Med. 2012;209:1309-1324. [PMID: 22734048 DOI: 10.1084/jem.20120239] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
311 Mao X, Jakubovics NS, Bächle M, Buchalla W, Hiller KA, Maisch T, Hellwig E, Kirschneck C, Gessner A, Al-Ahmad A, Cieplik F. Colonization of Helicobacter pylori in the oral cavity - an endless controversy? Crit Rev Microbiol 2021;47:612-29. [PMID: 33899666 DOI: 10.1080/1040841X.2021.1907740] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
312 Sicinschi LA, Correa P, Peek RM, Camargo MC, Piazuelo MB, Romero-Gallo J, Hobbs SS, Krishna U, Delgado A, Mera R, Bravo LE, Schneider BG. CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clin Microbiol Infect. 2010;16:369-378. [PMID: 19456839 DOI: 10.1111/j.1469-0691.2009.02811.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 4.9] [Reference Citation Analysis]
313 Bagheri V, Memar B, Momtazi AA, Sahebkar A, Gholamin M, Abbaszadegan MR. Cytokine networks and their association with Helicobacter pylori infection in gastric carcinoma. J Cell Physiol. 2018;233:2791-2803. [PMID: 28121015 DOI: 10.1002/jcp.25822] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
314 Ueda H, Ito M, Eguchi H, Tanaka S, Yoshihara M, Haruma K, Hatakeyama M, Chayama K. Development of a novel method to detect Helicobacter pylori cagA genotype from paraffin-embedded materials: comparison between patients with duodenal ulcer and gastric cancer in young Japanese. Digestion. 2006;73:47-53. [PMID: 16543737 DOI: 10.1159/000092014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
315 Ogawa T, Wada Y, Takemura K, Board PG, Uchida K, Kitagaki K, Tamura T, Suzuki T, Tokairin Y, Nakajima Y, Eishi Y. CHAC1 overexpression in human gastric parietal cells with Helicobacter pylori infection in the secretory canaliculi. Helicobacter 2019;24:e12598. [PMID: 31111570 DOI: 10.1111/hel.12598] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
316 Tohidpour A, Gorrell RJ, Roujeinikova A, Kwok T. The Middle Fragment of Helicobacter pylori CagA Induces Actin Rearrangement and Triggers Its Own Uptake into Gastric Epithelial Cells. Toxins (Basel) 2017;9:E237. [PMID: 28788072 DOI: 10.3390/toxins9080237] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
317 Tsugawa H, Kato C, Mori H, Matsuzaki J, Kameyama K, Saya H, Hatakeyama M, Suematsu M, Suzuki H. Cancer Stem-Cell Marker CD44v9-Positive Cells Arise From Helicobacter pylori-Infected CAPZA1-Overexpressing Cells. Cell Mol Gastroenterol Hepatol 2019;8:319-34. [PMID: 31146068 DOI: 10.1016/j.jcmgh.2019.05.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
318 Stein M, Ruggiero P, Rappuoli R, Bagnoli F. Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer Vaccine. Front Immunol. 2013;4:328. [PMID: 24133496 DOI: 10.3389/fimmu.2013.00328] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
319 Bronte-Tinkew DM, Terebiznik M, Franco A, Ang M, Ahn D, Mimuro H, Sasakawa C, Ropeleski MJ, Peek RM Jr, Jones NL. Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res 2009;69:632-9. [PMID: 19147578 DOI: 10.1158/0008-5472.CAN-08-1191] [Cited by in Crossref: 94] [Cited by in F6Publishing: 56] [Article Influence: 7.2] [Reference Citation Analysis]
320 Chang CC, Kuo WS, Chen YC, Perng CL, Lin HJ, Ou YH. Fragmentation of CagA Reduces Hummingbird Phenotype Induction by Helicobactor pylori. PLoS One 2016;11:e0150061. [PMID: 26934189 DOI: 10.1371/journal.pone.0150061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
321 Uchida T, Nguyen LT, Takayama A, Okimoto T, Kodama M, Murakami K, Matsuhisa T, Trinh TD, Ta L, Ho DQ. Analysis of virulence factors of Helicobacter pylori isolated from a Vietnamese population. BMC Microbiol. 2009;9:175. [PMID: 19698173 DOI: 10.1186/1471-2180-9-175] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
322 Sekiguchi H, Takabayashi F, Irie K, Murakami A. Auraptene attenuates gastritis via reduction of Helicobacter pylori colonization and pro-inflammatory mediator production in C57BL/6 mice. J Med Food. 2012;15:658-663. [PMID: 22471969 DOI: 10.1089/jmf.2011.1844] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
323 Chen Z, Zhou R, Zhang Y, Hao D, Wang Y, Huang S, Liu N, Xia C, Yissachar N, Huang F, Chu Y, Yan D. β-arrestin 2 quenches TLR signaling to facilitate the immune evasion of EPEC. Gut Microbes 2020;11:1423-37. [PMID: 32403971 DOI: 10.1080/19490976.2020.1759490] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
324 Keikha M, Eslami M, Yousefi B, Ghasemian A, Karbalaei M. Potential antigen candidates for subunit vaccine development against Helicobacter pylori infection. J Cell Physiol 2019;234:21460-70. [DOI: 10.1002/jcp.28870] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
325 Tang C, Zhou X, Yang H, Wang Q, Zhang R. [Expression and its clinical significance of SHP2 in non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi 2010;13:98-101. [PMID: 20673499 DOI: 10.3779/j.issn.1009-3419.2010.02.03] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
326 Queiroz DM, Silva CI, Goncalves MH, Braga-Neto MB, Fialho AB, Fialho AM, Rocha GA, Rocha AM, Batista SA, Guerrant RL, Lima AA, Braga LL. Higher frequency of cagA EPIYA-C phosphorylation sites in H. pylori strains from first-degree relatives of gastric cancer patients. BMC Gastroenterol. 2012;12:107. [PMID: 22891666 DOI: 10.1186/1471-230x-12-107] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
327 Suzuki M, Suzuki H, Minegishi Y, Ito K, Nishizawa T, Hibi T. H. Pylori-Eradication Therapy Increases RUNX3 Expression in the Glandular Epithelial Cells in Enlarged-Fold Gastritis. J Clin Biochem Nutr. 2010;46:259-264. [PMID: 20490322 DOI: 10.3164/jcbn.09-127] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
328 Miftahussurur M, Yamaoka Y, Graham DY. Helicobacter pylori as an oncogenic pathogen, revisited. Expert Rev Mol Med. 2017;19:e4. [PMID: 28322182 DOI: 10.1017/erm.2017.4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
329 Necchi V, Sommi P, Vanoli A, Manca R, Ricci V, Solcia E. Proteasome particle-rich structures are widely present in human epithelial neoplasms: correlative light, confocal and electron microscopy study. PLoS One 2011;6:e21317. [PMID: 21695063 DOI: 10.1371/journal.pone.0021317] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
330 Chaiyadet S, Smout M, Johnson M, Whitchurch C, Turnbull L, Kaewkes S, Sotillo J, Loukas A, Sripa B. Excretory/secretory products of the carcinogenic liver fluke are endocytosed by human cholangiocytes and drive cell proliferation and IL6 production. Int J Parasitol 2015;45:773-81. [PMID: 26187786 DOI: 10.1016/j.ijpara.2015.06.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
331 Magalhães A, Marcos NT, Carvalho AS, David L, Figueiredo C, Bastos J, David G, Reis CA. Helicobacter pylori cag pathogenicity island-positive strains induce syndecan-4 expression in gastric epithelial cells. FEMS Immunol Med Microbiol 2009;56:223-32. [DOI: 10.1111/j.1574-695x.2009.00569.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
332 Shi D, Liu Y, Wu D, Hu X. Transfection of the Helicobacter pylori CagA gene alters MUC5AC expression in human gastric cancer cells. Oncol Lett 2018;15:5208-12. [PMID: 29552159 DOI: 10.3892/ol.2018.7960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
333 Yang JJ, Cho LY, Ma SH, Ko KP, Shin A, Choi BY, Han DS, Song KS, Kim YS, Chang SH. Oncogenic CagA promotes gastric cancer risk via activating ERK signaling pathways: a nested case-control study. PLoS One. 2011;6:e21155. [PMID: 21698158 DOI: 10.1371/journal.pone.0021155] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
334 Acosta N, Quiroga A, Delgado P, Bravo MM, Jaramillo C. Helicobacter pylori CagA protein polymorphisms and their lack of association with pathogenesis. World J Gastroenterol 2010; 16(31): 3936-3943 [PMID: 20712055 DOI: 10.3748/wjg.v16.i31.3936] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
335 Keikha M, Karbalaei M. EPIYA motifs of Helicobacter pylori cagA genotypes and gastrointestinal diseases in the Iranian population: a systematic review and meta-analysis. New Microbes New Infect 2021;41:100865. [PMID: 33912350 DOI: 10.1016/j.nmni.2021.100865] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
336 Yong X, Tang B, Li BS, Xie R, Hu CJ, Luo G, Qin Y, Dong H, Yang SM. Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways. Cell Commun Signal. 2015;13:30. [PMID: 26160167 DOI: 10.1186/s12964-015-0111-0] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 11.1] [Reference Citation Analysis]
337 Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol. 2010;7:629-641. [PMID: 20938460 DOI: 10.1038/nrgastro.2010.154] [Cited by in Crossref: 369] [Cited by in F6Publishing: 338] [Article Influence: 30.8] [Reference Citation Analysis]
338 Shang W, Wang Y, Liang X, Li T, Shao W, Liu F, Cui X, Wang Y, Lv L, Chai L, Qu L, Zheng L, Jia J. SETDB1 promotes gastric carcinogenesis and metastasis via upregulation of CCND1 and MMP9 expression. J Pathol 2021;253:148-59. [PMID: 33044755 DOI: 10.1002/path.5568] [Reference Citation Analysis]
339 Bakhti SZ, Latifi-Navid S, Zahri S, Bakhti FS, Hajavi N, Yazdanbod A. Are Helicobacter pylori highly cytotoxic genotypes and cardia gastric adenocarcinoma linked? Lessons from Iran. Cancer Biomark. 2017;21:235-246. [PMID: 29036792 DOI: 10.3233/cbm-170701] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
340 Bagheri N, Azadegan-Dehkordi F, Rafieian-Kopaei M, Rahimian G, Asadi-Samani M, Shirzad H. Clinical relevance of Helicobacter pylori virulence factors in Iranian patients with gastrointestinal diseases. Microb Pathog. 2016;100:154-162. [PMID: 27666510 DOI: 10.1016/j.micpath.2016.09.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
341 King CC, Obonyo M. Helicobacter pylori modulates host cell survival regulation through the serine-threonine kinase, 3-phosphoinositide dependent kinase 1 (PDK-1). BMC Microbiol. 2015;15:222. [PMID: 26487493 DOI: 10.1186/s12866-015-0543-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
342 Zhao L, Long X, Yao J, Wang C, Ma Y, Huang Y, Li Y, Wang M, Fu G. Genetic polymorphism of XRCC3 codon 241 and Helicobacter pylori infection-related gastric antrum adenocarcinoma in Guangxi Population, China: A hospital-based case–control study. Cancer Epidemiology 2011;35:564-8. [DOI: 10.1016/j.canep.2011.03.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
343 Zeng X, Li Y, Liu T, Zhang J. Diverse H. pylori strains, IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China. Mol Cell Biochem. 2012;362:241-248. [PMID: 22081333 DOI: 10.1007/s11010-011-1149-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
344 Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, Higashi H, Musashi M, Iwabuchi K, Suzuki M, Yamada G, Azuma T, Hatakeyama M. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA. 2008;105:1003-1008. [PMID: 18192401 DOI: 10.1073/pnas.0711183105] [Cited by in Crossref: 408] [Cited by in F6Publishing: 389] [Article Influence: 29.1] [Reference Citation Analysis]
345 Ubukata H, Nagata H, Tabuchi T, Konishi S, Kasuga T, Tabuchi T. Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer. Gastric Cancer. 2011;14:4-12. [PMID: 21249411 DOI: 10.1007/s10120-011-0005-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
346 Ponzetto A, Perez-Perez GI, Figura N. Alpha1-antitrypsin deficiency and c-JUN. Hepatology 2017;66:677. [PMID: 28437866 DOI: 10.1002/hep.29231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
347 Kuo SH, Wu MS, Yeh KH, Lin CW, Hsu PN, Chen LT, Cheng AL. Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Cancers (Basel) 2019;11:E547. [PMID: 30999581 DOI: 10.3390/cancers11040547] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
348 Ponzetto A, Figura N. Risk of Hepatocellular Carcinoma After Cure of Hepatitis C Virus. Gastroenterology 2018;154:1549. [DOI: 10.1053/j.gastro.2017.12.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
349 Peek RM Jr. Pathogenesis of Helicobacter pylori infection. Springer Semin Immunopathol 2005;27:197-215. [PMID: 15928915 DOI: 10.1007/s00281-005-0204-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
350 Yáñez MA, Barberá VM, Soria E, Catalán V. Quantitative detection of Helicobacter pylori in water samples by real-time PCR amplification of the cag pathogenicity island gene, cagE. J Appl Microbiol 2009;107:416-24. [PMID: 19302298 DOI: 10.1111/j.1365-2672.2009.04219.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
351 Chen Y, Segers S, Blaser MJ. Association between Helicobacter pylori and mortality in the NHANES III study. Gut 2013;62:1262-9. [PMID: 23303440 DOI: 10.1136/gutjnl-2012-303018] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 7.1] [Reference Citation Analysis]
352 Lin CF, Lin CM, Lee KY, Wu SY, Feng PH, Chen KY, Chuang HC, Chen CL, Wang YC, Tseng PC, Tsai TT. Escape from IFN-γ-dependent immunosurveillance in tumorigenesis. J Biomed Sci 2017;24:10. [PMID: 28143527 DOI: 10.1186/s12929-017-0317-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 9.2] [Reference Citation Analysis]
353 Selgrad M, Malfertheiner P, Fini L, Goel A, Boland CR, Ricciardiello L. The role of viral and bacterial pathogens in gastrointestinal cancer. J Cell Physiol 2008;216:378-88. [PMID: 18338378 DOI: 10.1002/jcp.21427] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
354 Anderson JC, Pascuzzi PE, Xiao F, Sessa G, Martin GB. Host-mediated phosphorylation of type III effector AvrPto promotes Pseudomonas virulence and avirulence in tomato. Plant Cell 2006;18:502-14. [PMID: 16399801 DOI: 10.1105/tpc.105.036590] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
355 Chen Y, Blaser MJ. Association between gastric Helicobacter pylori colonization and glycated hemoglobin levels. J Infect Dis 2012;205:1195-202. [PMID: 22427676 DOI: 10.1093/infdis/jis106] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
356 Giraud AS, Jackson C, Menheniott TR, Judd LM. Differentiation of the Gastric Mucosa IV. Role of trefoil peptides and IL-6 cytokine family signaling in gastric homeostasis. Am J Physiol Gastrointest Liver Physiol 2007;292:G1-5. [PMID: 16935852 DOI: 10.1152/ajpgi.00382.2006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
357 Tsutsumi R, Takahashi A, Azuma T, Higashi H, Hatakeyama M. Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol Cell Biol 2006;26:261-76. [PMID: 16354697 DOI: 10.1128/MCB.26.1.261-276.2006] [Cited by in Crossref: 143] [Cited by in F6Publishing: 74] [Article Influence: 8.9] [Reference Citation Analysis]
358 Jarzab M, Posselt G, Meisner-Kober N, Wessler S. Helicobacter pylori-Derived Outer Membrane Vesicles (OMVs): Role in Bacterial Pathogenesis? Microorganisms 2020;8:E1328. [PMID: 32878302 DOI: 10.3390/microorganisms8091328] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
359 Matos JI, de Sousa HA, Marcos-pinto R, Dinis-ribeiro M. Helicobacter pylori CagA and VacA genotypes and gastric phenotype: a meta-analysis. European Journal of Gastroenterology & Hepatology 2013;25:1431-41. [DOI: 10.1097/meg.0b013e328364b53e] [Cited by in Crossref: 62] [Cited by in F6Publishing: 34] [Article Influence: 6.9] [Reference Citation Analysis]
360 Senda Y, Hatakeyama M. CagA. In: Suzuki H, Warren R, Marshall B, editors. Helicobacter pylori. Tokyo: Springer Japan; 2016. pp. 33-47. [DOI: 10.1007/978-4-431-55705-0_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
361 Higashi H, Yokoyama K, Fujii Y, Ren S, Yuasa H, Saadat I, Murata-kamiya N, Azuma T, Hatakeyama M. EPIYA Motif Is a Membrane-targeting Signal of Helicobacter pylori Virulence Factor CagA in Mammalian Cells. Journal of Biological Chemistry 2005;280:23130-7. [DOI: 10.1074/jbc.m503583200] [Cited by in Crossref: 98] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
362 Hatakeyama M. The role of Helicobacter pylori CagA in gastric carcinogenesis. Int J Hematol 2006;84:301-8. [PMID: 17118755 DOI: 10.1532/IJH97.06166] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
363 Suzuki R, Shiota S, Yamaoka Y. Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori. Infect Genet Evol. 2012;12:203-213. [PMID: 22197766 DOI: 10.1016/j.meegid.2011.12.002] [Cited by in Crossref: 97] [Cited by in F6Publishing: 82] [Article Influence: 8.8] [Reference Citation Analysis]
364 Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev 2020;39:1179-203. [PMID: 32894370 DOI: 10.1007/s10555-020-09925-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
365 Hitkova I, Yuan G, Anderl F, Gerhard M, Kirchner T, Reu S, Röcken C, Schäfer C, Schmid RM, Vogelmann R. Caveolin-1 protects B6129 mice against Helicobacter pylori gastritis. PLoS Pathog. 2013;9:e1003251. [PMID: 23592983 DOI: 10.1371/journal.ppat.1003251] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
366 Frydman GH, Davis N, Beck PL, Fox JG. Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography. Helicobacter 2015;20:239-51. [PMID: 25728540 DOI: 10.1111/hel.12200] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
367 Menheniott TR, Judd LM, Giraud AS. STAT3: a critical component in the response to Helicobacter pylori infection. Cell Microbiol 2015;17:1570-82. [PMID: 26332850 DOI: 10.1111/cmi.12518] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
368 Miftahussurur M, Waskito LA, Fauzia KA, Mahmudah I, Doohan D, Adnyana IK, Khomsan A, Ratnasari N, Rezkitha YAA. Overview of Helicobacter pylori Infection in Indonesia: What Distinguishes It from Countries with High Gastric Cancer Incidence? Gut Liver 2021;15:653-65. [PMID: 32616679 DOI: 10.5009/gnl20019] [Reference Citation Analysis]
369 Brüggemann H, Al-Zeer MA. Bacterial signatures and their inflammatory potentials associated with prostate cancer. APMIS 2020;128:80-91. [PMID: 31990107 DOI: 10.1111/apm.13021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
370 Shapla UM, Raihan J, Islam A, Alam F, Solayman N, Gan SH, Hossen S, Khalil I. Propolis: The future therapy against Helicobacter pylori-mediated gastrointestinal diseases. J Appl Biomed 2018;16:81-99. [DOI: 10.1016/j.jab.2017.10.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
371 Watanabe T, Asano N, Kitani A, Fuss IJ, Chiba T, Strober W. Activation of type I IFN signaling by NOD1 mediates mucosal host defense against Helicobacter pylori infection. Gut Microbes. 2011;2:61-65. [PMID: 21637021 DOI: 10.4161/gmic.2.1.15162] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
372 Phan TN, Santona A, Tran VH, Tran TNH, Le VA, Cappuccinelli P, Rubino S, Paglietti B. Genotyping of Helicobacter pylori shows high diversity of strains circulating in central Vietnam. Infection, Genetics and Evolution 2017;52:19-25. [DOI: 10.1016/j.meegid.2017.04.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
373 Devi SM, Ahmed I, Francalacci P, Hussain MA, Akhter Y, Alvi A, Sechi LA, Mégraud F, Ahmed N. Ancestral European roots of Helicobacter pylori in India. BMC Genomics. 2007;8:184. [PMID: 17584914 DOI: 10.1186/1471-2164-8-184] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
374 Algood HM, Cover TL. Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev. 2006;19:597-613. [PMID: 17041136 DOI: 10.1128/cmr.00006-06] [Cited by in Crossref: 159] [Cited by in F6Publishing: 80] [Article Influence: 9.9] [Reference Citation Analysis]
375 Tserentogtokh T, Gantuya B, Subsomwong P, Oyuntsetseg K, Bolor D, Erdene-Ochir Y, Azzaya D, Davaadorj D, Uchida T, Matsuhisa T, Yamaoka Y. Western-Type Helicobacter pylori CagA are the Most Frequent Type in Mongolian Patients. Cancers (Basel) 2019;11:E725. [PMID: 31137742 DOI: 10.3390/cancers11050725] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
376 Wen Y, Huang H, Tang T, Yang H, Wang X, Huang X, Gong Y, Zhang X, She F. AI-2 represses CagA expression and bacterial adhesion, attenuating the Helicobacter pylori-induced inflammatory response of gastric epithelial cells. Helicobacter 2021;26:e12778. [PMID: 33400843 DOI: 10.1111/hel.12778] [Reference Citation Analysis]
377 Rottner K, Stradal TE, Wehland J. Bacteria-host-cell interactions at the plasma membrane: stories on actin cytoskeleton subversion. Dev Cell 2005;9:3-17. [PMID: 15992537 DOI: 10.1016/j.devcel.2005.06.002] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 4.6] [Reference Citation Analysis]
378 Pucułek M, Machlowska J, Wierzbicki R, Baj J, Maciejewski R, Sitarz R. Helicobacter pylori associated factors in the development of gastric cancer with special reference to the early-onset subtype. Oncotarget 2018;9:31146-62. [PMID: 30123433 DOI: 10.18632/oncotarget.25757] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
379 Wang YC, Chen CL, Sheu BS, Yang YJ, Tseng PC, Hsieh CY, Lin CF. Helicobacter pylori infection activates Src homology-2 domain-containing phosphatase 2 to suppress IFN-γ signaling. J Immunol 2014;193:4149-58. [PMID: 25225672 DOI: 10.4049/jimmunol.1400594] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
380 Pajavand H, Alvandi A, Mohajeri P, Bakhtyari S, Bashiri H, Kalali B, Gerhard M, Najafi F, Abiri R. High Frequency of vacA s1m2 Genotypes Among Helicobacter pylori Isolates From Patients With Gastroduodenal Disorders in Kermanshah, Iran. Jundishapur J Microbiol. 2015;8:e25425. [PMID: 26862378 DOI: 10.5812/jjm.25425] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
381 Nakayama C, Yamamichi N, Tomida S, Takahashi Y, Kageyama-Yahara N, Sakurai K, Takeuchi C, Inada KI, Shiogama K, Nagae G, Ono S, Tsuji Y, Niimi K, Fujishiro M, Aburatani H, Tsutsumi Y, Koike K. Transduced caudal-type homeobox (CDX) 2/CDX1 can induce growth inhibition on CDX-deficient gastric cancer by rapid intestinal differentiation. Cancer Sci 2018;109:3853-64. [PMID: 30289576 DOI: 10.1111/cas.13821] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
382 Xia HHX, Lam SK, Chan AO, Lin MCM, Kung HF, Ogura K, Berg DE, Wong BCY. Macrophage migration inhibitory factor stimulated by Helicobacter pylori increases proliferation of gastric epithelial cells. World J Gastroenterol 2005; 11(13): 1946-1950 [PMID: 15800984 DOI: 10.3748/wjg.v11.i13.1946] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
383 Kurago ZB, Lam-ubol A, Stetsenko A, De La Mater C, Chen Y, Dawson DV. Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation. Head Neck Pathol 2008;2:1-12. [PMID: 19603082 DOI: 10.1007/s12105-007-0038-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
384 Fontanillo M, Köhn M. Phosphatases: Their Roles in Cancer and Their Chemical Modulators. Adv Exp Med Biol 2016;917:209-40. [PMID: 27236558 DOI: 10.1007/978-3-319-32805-8_10] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
385 Chen ZM, Hu J, Xu YM, He W, Meng L, Huang T, Ying SC, Jiang Z, Xu AM. Cryptotanshinone inhibits cytotoxin-associated gene A-associated development of gastric cancer and mucosal erosions. World J Gastrointest Oncol 2021; 13(7): 693-705 [PMID: 34322198 DOI: 10.4251/wjgo.v13.i7.693] [Reference Citation Analysis]
386 Vianna JS, Ramis IB, Halicki PC, Gastal OL, Silva RA, Junior JS, Dos Santos DM, Chaves AL, Juliano CR, Jannke HA. Detection of Helicobacter pylori CagA EPIYA in gastric biopsy specimens and its relation to gastric diseases. Diagn Microbiol Infect Dis. 2015;83:89-92. [PMID: 26144892 DOI: 10.1016/j.diagmicrobio.2015.05.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
387 LaCourse KD, Johnston CD, Bullman S. The relationship between gastrointestinal cancers and the microbiota. Lancet Gastroenterol Hepatol 2021;6:498-509. [PMID: 33743198 DOI: 10.1016/S2468-1253(20)30362-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
388 Devi S, Ansari SA, Tenguria S, Kumar N, Ahmed N. Multipronged regulatory functions of a novel endonuclease (TieA) from Helicobacter pylori. Nucleic Acids Res 2016;44:9393-412. [PMID: 27550181 DOI: 10.1093/nar/gkw730] [Reference Citation Analysis]
389 Yu ZH, Chen L, Wu L, Liu S, Wang L, Zhang ZY. Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening. Bioorg Med Chem Lett 2011;21:4238-42. [PMID: 21669525 DOI: 10.1016/j.bmcl.2011.05.078] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
390 Rasch S, Algül H. A clinical perspective on the role of chronic inflammation in gastrointestinal cancer. Clin Exp Gastroenterol 2014;7:261-72. [PMID: 25143751 DOI: 10.2147/CEG.S43457] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
391 Nagata M, Toyonaga K, Ishikawa E, Haji S, Okahashi N, Takahashi M, Izumi Y, Imamura A, Takato K, Ishida H, Nagai S, Illarionov P, Stocker BL, Timmer MSM, Smith DGM, Williams SJ, Bamba T, Miyamoto T, Arita M, Appelmelk BJ, Yamasaki S. Helicobacter pylori metabolites exacerbate gastritis through C-type lectin receptors. J Exp Med 2021;218:e20200815. [PMID: 32991669 DOI: 10.1084/jem.20200815] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
392 Lv Z, Zhao L, Jin W. Protein changes in gastric epithelial cells RGM-1 in response to Helicobacter pylori infection. J Cell Biochem 2019;120:3197-202. [PMID: 30582187 DOI: 10.1002/jcb.27585] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
393 Safari F, Murata-Kamiya N, Saito Y, Hatakeyama M. Mammalian Pragmin regulates Src family kinases via the Glu-Pro-Ile-Tyr-Ala (EPIYA) motif that is exploited by bacterial effectors. Proc Natl Acad Sci U S A 2011;108:14938-43. [PMID: 21873224 DOI: 10.1073/pnas.1107740108] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
394 Tao Y, Xie J, Zhong Q, Wang Y, Zhang S, Luo F, Wen F, Xie J, Zhao J, Sun X, Long H, Ma J, Zhang Q, Long J, Fang X, Lu Y, Li D, Li M, Zhu J, Sun B, Li G, Diao J, Liu C. A novel partially open state of SHP2 points to a "multiple gear" regulation mechanism. J Biol Chem 2021;296:100538. [PMID: 33722610 DOI: 10.1016/j.jbc.2021.100538] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
395 Yu ZH, Zhang ZY. Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases. Chem Rev 2018;118:1069-91. [PMID: 28541680 DOI: 10.1021/acs.chemrev.7b00105] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 9.2] [Reference Citation Analysis]
396 Yang W, Wang J, Moore DC, Liang H, Dooner M, Wu Q, Terek R, Chen Q, Ehrlich MG, Quesenberry PJ, Neel BG. Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling. Nature 2013;499:491-5. [PMID: 23863940 DOI: 10.1038/nature12396] [Cited by in Crossref: 120] [Cited by in F6Publishing: 117] [Article Influence: 13.3] [Reference Citation Analysis]
397 Kocazeybek BS, Caliskan R, Erdamar Cetin S, Ergin S, Kuskucu M, Kepil N, Oyku Dinc H, Ziya Erzin Y, Saribas S, Bahar Tokman H. Patterns of EPIYA motifs among cagA-positive Helicobacter pylori strains: a case-control study in a Turkish population with Eurasian geographical features. J Med Microbiol. 2015;64:1117-1123. [PMID: 26198695 DOI: 10.1099/jmm.0.000141] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
398 Mohi MG, Neel BG. The role of Shp2 (PTPN11) in cancer. Curr Opin Genet Dev. 2007;17:23-30. [PMID: 17227708 DOI: 10.1016/j.gde.2006.12.011] [Cited by in Crossref: 165] [Cited by in F6Publishing: 166] [Article Influence: 11.0] [Reference Citation Analysis]
399 Tanaka S, Nagashima H, Cruz M, Uchida T, Uotani T, Jiménez Abreu JA, Mahachai V, Vilaichone RK, Ratanachu-Ek T, Tshering L, Graham DY, Yamaoka Y. Interleukin-17C in Human Helicobacter pylori Gastritis. Infect Immun 2017;85:e00389-17. [PMID: 28739826 DOI: 10.1128/IAI.00389-17] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
400 Akhavan-Niaki H, Samadani AA. Molecular insight in gastric cancer induction: an overview of cancer stemness genes. Cell Biochem Biophys. 2014;68:463-473. [PMID: 24078401 DOI: 10.1007/s12013-013-9749-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
401 Liu Z, Xu X, Chen L, Li W, Sun Y, Zeng J, Yu H, Chen C, Jia J. Helicobacter pylori CagA inhibits the expression of Runx3 via Src/MEK/ERK and p38 MAPK pathways in gastric epithelial cell. J Cell Biochem 2012;113:1080-6. [DOI: 10.1002/jcb.23440] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
402 Mendoza-Elizalde S, Cortés-Márquez AC, Zuñiga G, Cerritos R, Valencia-Mayoral P, Sánchez AC, Olivares-Clavijo H, Velázquez-Guadarrama N. Inference from the analysis of genetic structure of Helicobacter pylori strains isolates from two paediatric patients with recurrent infection. BMC Microbiol 2019;19:184. [PMID: 31395006 DOI: 10.1186/s12866-019-1554-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
403 Robinson KM, Crabtree J, Mattick JS, Anderson KE, Dunning Hotopp JC. Distinguishing potential bacteria-tumor associations from contamination in a secondary data analysis of public cancer genome sequence data. Microbiome 2017;5:9. [PMID: 28118849 DOI: 10.1186/s40168-016-0224-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
404 Jiang ZX, Zhang ZY. Targeting PTPs with small molecule inhibitors in cancer treatment. Cancer Metastasis Rev 2008;27:263-72. [PMID: 18259840 DOI: 10.1007/s10555-008-9113-3] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 5.9] [Reference Citation Analysis]
405 Naito M, Yamazaki T, Tsutsumi R, Higashi H, Onoe K, Yamazaki S, Azuma T, Hatakeyama M. Influence of EPIYA-Repeat Polymorphism on the Phosphorylation-Dependent Biological Activity of Helicobacter pylori CagA. Gastroenterology 2006;130:1181-90. [DOI: 10.1053/j.gastro.2005.12.038] [Cited by in Crossref: 143] [Cited by in F6Publishing: 135] [Article Influence: 8.9] [Reference Citation Analysis]
406 Chen L, Sung S, Yip MLR, Lawrence HR, Ren Y, Guida WC, Sebti SM, Lawrence NJ, Wu J. Discovery of a Novel Shp2 Protein Tyrosine Phosphatase Inhibitor. Mol Pharmacol 2006;70:562-70. [DOI: 10.1124/mol.106.025536] [Cited by in Crossref: 188] [Cited by in F6Publishing: 174] [Article Influence: 11.8] [Reference Citation Analysis]
407 Tsugawa H, Suzuki H, Saya H, Hatakeyama M, Hirayama T, Hirata K, Nagano O, Matsuzaki J, Hibi T. Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe. 2012;12:764-777. [PMID: 23245321 DOI: 10.1016/j.chom.2012.10.014] [Cited by in Crossref: 151] [Cited by in F6Publishing: 130] [Article Influence: 16.8] [Reference Citation Analysis]
408 Nosrati R, Golichenari B, Nezami A, Taghdisi SM, Karimi B, Ramezani M, Abnous K, Shaegh SAM. Helicobacter pylori point-of-care diagnosis: Nano-scale biosensors and microfluidic systems. TrAC Trends in Analytical Chemistry 2017;97:428-44. [DOI: 10.1016/j.trac.2017.10.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
409 Jiménez-Soto LF, Kutter S, Sewald X, Ertl C, Weiss E, Kapp U, Rohde M, Pirch T, Jung K, Retta SF. Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner. PLoS Pathog. 2009;5:e1000684. [PMID: 19997503 DOI: 10.1371/journal.ppat.1000684] [Cited by in Crossref: 170] [Cited by in F6Publishing: 171] [Article Influence: 13.1] [Reference Citation Analysis]
410 Noto JM, Peek RM Jr. The Helicobacter pylori cag Pathogenicity Island. Methods Mol Biol 2012;921:41-50. [PMID: 23015490 DOI: 10.1007/978-1-62703-005-2_7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
411 Takayama S, Wakasugi T, Funahashi H, Takeyama H. Strategies for gastric cancer in the modern era. World J Gastrointest Oncol 2010; 2(9): 335-341 [PMID: 21160804 DOI: 10.4251/wjgo.v2.i9.335] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
412 Wang MY, Liu XF, Gao XZ. Helicobacter pylori virulence factors in development of gastric carcinoma. Future Microbiol. 2015;10:1505-1516. [PMID: 26346770 DOI: 10.2217/fmb.15.72] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
413 Chung WC, Jung SH, Joo KR, Kim MJ, Youn GJ, Kim Y, Lee JS, Lee H, Jung JH, Lee YK. An inverse relationship between the expression of the gastric tumor suppressor RUNX3 and infection with Helicobacter pylori in gastric epithelial dysplasia. Gut Liver 2013;7:688-95. [PMID: 24312710 DOI: 10.5009/gnl.2013.7.6.688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
414 Katayama Y, Takahashi M, Kuwayama H. Helicobacter pylori causes runx3 gene methylation and its loss of expression in gastric epithelial cells, which is mediated by nitric oxide produced by macrophages. Biochem Biophys Res Commun. 2009;388:496-500. [PMID: 19665002 DOI: 10.1016/j.bbrc.2009.08.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
415 Bornschein J, Weigt J, Selgrad M, Malfertheiner P. Molecular aspects in the diagnosis of gastric cancer. Expert Opin Med Diagn 2009;3:585-96. [PMID: 23495987 DOI: 10.1517/17530050902862175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
416 Lee DG, Kim HS, Lee YS, Kim S, Cha SY, Ota I, Kim NH, Cha YH, Yang DH, Lee Y. Helicobacter pylori CagA promotes Snail-mediated epithelial-mesenchymal transition by reducing GSK-3 activity. Nat Commun. 2014;5:4423. [PMID: 25055241 DOI: 10.1038/ncomms5423] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
417 Subsomwong P, Miftahussurur M, Vilaichone RK, Ratanachu-Ek T, Suzuki R, Akada J, Uchida T, Mahachai V, Yamaoka Y. Helicobacter pylori virulence genes of minor ethnic groups in North Thailand. Gut Pathog 2017;9:56. [PMID: 29046726 DOI: 10.1186/s13099-017-0205-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
418 Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method". Proc Jpn Acad Ser B Phys Biol Sci 2011;87:405-14. [PMID: 21785258 DOI: 10.2183/pjab.87.405] [Cited by in Crossref: 123] [Cited by in F6Publishing: 120] [Article Influence: 12.3] [Reference Citation Analysis]
419 Lu H, Murata-Kamiya N, Saito Y, Hatakeyama M. Role of partitioning-defective 1/microtubule affinity-regulating kinases in the morphogenetic activity of Helicobacter pylori CagA. J Biol Chem. 2009;284:23024-23036. [PMID: 19553659 DOI: 10.1074/jbc.m109.001008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
420 Lu HS, Saito Y, Umeda M, Murata-Kamiya N, Zhang HM, Higashi H, Hatakeyama M. Structural and functional diversity in the PAR1b/MARK2-binding region of Helicobacter pylori CagA. Cancer Sci. 2008;99:2004-2011. [PMID: 19016760 DOI: 10.1111/j.1349-7006.2008.00950.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 34] [Article Influence: 0.7] [Reference Citation Analysis]
421 Sasaki T, Yamashita Y, Kuniyasu H. AKT plays a crucial role in gastric cancer. Oncol Lett 2015;10:607-11. [PMID: 26622541 DOI: 10.3892/ol.2015.3260] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
422 Fujii Y, Murata-Kamiya N, Hatakeyama M. Helicobacter pylori CagA oncoprotein interacts with SHIP2 to increase its delivery into gastric epithelial cells. Cancer Sci 2020;111:1596-606. [PMID: 32198795 DOI: 10.1111/cas.14391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
423 Ponzetto A, Figura N. Screening for Gastric Cancer. Am J Gastroenterol 2019;114:690. [PMID: 30676379 DOI: 10.14309/ajg.0000000000000110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
424 Lu H, Yamaoka Y, Graham DY. Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol. 2005;21:653-659. [PMID: 16220040 DOI: 10.1097/01.mog.0000181711.04529.d5] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 4.9] [Reference Citation Analysis]
425 Jiang J, Jin MS, Kong F, Wang YP, Jia ZF, Cao DH, Ma HX, Suo J, Cao XY. Increased expression of tyrosine phosphatase SHP-2 in Helicobacter pylori-infected gastric cancer. World J Gastroenterol 2013; 19(4): 575-580 [PMID: 23382639 DOI: 10.3748/wjg.v19.i4.575] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
426 Ricci V, Romano M, Boquet P. Molecular cross-talk between Helicobacter pylori and human gastric mucosa. World J Gastroenterol 2011; 17(11): 1383-1399 [PMID: 21472096 DOI: 10.3748/wjg.v17.i11.1383] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
427 Dong S, Li FQ, Zhang Q, Lv KZ, Yang HL, Gao Y, Yu JR. Expression and clinical significance of SHP2 in gastric cancer. J Int Med Res. 2012;40:2083-2089. [PMID: 23321164 DOI: 10.1177/030006051204000605] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
428 Uotani T, Miftahussurur M, Yamaoka Y. Effect of bacterial and host factors on Helicobacter pylori eradication therapy. Expert Opin Ther Targets. 2015;19:1637-1650. [PMID: 26245678 DOI: 10.1517/14728222.2015.1073261] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
429 Kurashige J, Hasegawa T, Niida A, Sugimachi K, Deng N, Mima K, Uchi R, Sawada G, Takahashi Y, Eguchi H. Integrated molecular profiling of human gastric cancer identifies DDR2 as a potential regulator of peritoneal dissemination. Sci Rep. 2016;6:22371. [PMID: 26934957 DOI: 10.1038/srep22371] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
430 Silva-García O, Valdez-Alarcón JJ, Baizabal-Aguirre VM. Wnt/β-Catenin Signaling as a Molecular Target by Pathogenic Bacteria. Front Immunol 2019;10:2135. [PMID: 31611869 DOI: 10.3389/fimmu.2019.02135] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
431 Zhao R, Liu Z, Xu W, Song L, Ren H, Ou Y, Liu Y, Wang S. Helicobacter pylori infection leads to KLF4 inactivation in gastric cancer through a TET1-mediated DNA methylation mechanism. Cancer Med 2020;9:2551-63. [PMID: 32017451 DOI: 10.1002/cam4.2892] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
432 Ferreira CV, Justo GZ, Souza AC, Queiroz KC, Zambuzzi WF, Aoyama H, Peppelenbosch MP. Natural compounds as a source of protein tyrosine phosphatase inhibitors: application to the rational design of small-molecule derivatives. Biochimie 2006;88:1859-73. [PMID: 17010496 DOI: 10.1016/j.biochi.2006.08.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
433 Li W, Tian D, Guan X, Yun H, Wang H, Xiao Y, Bi C, Ying S, Su M. Esophageal intraepithelial invasion of Helicobacter pylori correlates with atypical hyperplasia: H. pylori Lead to Esophageal Carcinogenesis. Int J Cancer 2014;134:2626-32. [DOI: 10.1002/ijc.28588] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
434 Thanaphongdecha P, Karinshak SE, Ittiprasert W, Mann VH, Chamgramol Y, Pairojkul C, Fox JG, Suttiprapa S, Sripa B, Brindley PJ. Infection with Helicobacter pylori Induces Epithelial to Mesenchymal Transition in Human Cholangiocytes. Pathogens 2020;9:E971. [PMID: 33233485 DOI: 10.3390/pathogens9110971] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
435 Yamaoka Y. Pathogenesis of Helicobacter pylori-Related Gastroduodenal Diseases from Molecular Epidemiological Studies. Gastroenterol Res Pract. 2012;2012:371503. [PMID: 22829807 DOI: 10.1155/2012/371503] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 4.6] [Reference Citation Analysis]
436 Chew Y, Chung HY, Lin PY, Wu DC, Huang SK, Kao MC. Outer Membrane Vesicle Production by Helicobacter pylori Represents an Approach for the Delivery of Virulence Factors CagA, VacA and UreA into Human Gastric Adenocarcinoma (AGS) Cells. Int J Mol Sci 2021;22:3942. [PMID: 33920443 DOI: 10.3390/ijms22083942] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
437 Kim JM. H. pylori Virulence Factors: Toxins (CagA, VacA, DupA, OipA, IceA). In: Kim N, editor. Helicobacter pylori. Singapore: Springer; 2016. pp. 77-88. [DOI: 10.1007/978-981-287-706-2_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
438 Srivastava AK, Singh D, Roy BK. Structural Interactions of Curcumin Biotransformed Molecules with the N-Terminal Residues of Cytotoxic-Associated Gene A Protein Provide Insights into Suppression of Oncogenic Activities. Interdiscip Sci 2017;9:116-29. [PMID: 26798036 DOI: 10.1007/s12539-016-0142-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
439 Jang S, Jones KR, Olsen CH, Joo YM, Yoo YJ, Chung IS, Cha JH, Merrell DS. Epidemiological link between gastric disease and polymorphisms in VacA and CagA. J Clin Microbiol. 2010;48:559-567. [PMID: 19955279 DOI: 10.1128/jcm.01501-09] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
440 Lillehoj EP, Guang W, Ding H, Czinn SJ, Blanchard TG. Helicobacter pylori and Gastric Inflammation: Role of MUC1 Mucin. J Pediatr Biochem 2012;2:125-32. [PMID: 23667410 DOI: 10.3233/JPB-2012-00058] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
441 Gagnaire A, Nadel B, Raoult D, Neefjes J, Gorvel J. Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer. Nat Rev Microbiol 2017;15:109-28. [DOI: 10.1038/nrmicro.2016.171] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 15.8] [Reference Citation Analysis]
442 Ohba R, Iijima K. Pathogenesis and risk factors for gastric cancer after Helicobacter pylori eradication. World J Gastrointest Oncol 2016; 8(9): 663-672 [PMID: 27672424 DOI: 10.4251/wjgo.v8.i9.663] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
443 Hatakeyama M. Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93:196-219. [PMID: 28413197 DOI: 10.2183/pjab.93.013] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 12.2] [Reference Citation Analysis]
444 Syam AF, Miftahussurur M, Uwan WB, Simanjuntak D, Uchida T, Yamaoka Y. Validation of Urine Test for Detection of Helicobacter pylori Infection in Indonesian Population. Biomed Res Int. 2015;2015:152823. [PMID: 26824034 DOI: 10.1155/2015/152823] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
445 Muenst S, Obermann EC, Gao F, Oertli D, Viehl CT, Weber WP, Fleming T, Gillanders WE, Soysal SD. Src homology phosphotyrosyl phosphatase-2 expression is an independent negative prognostic factor in human breast cancer. Histopathology 2013;63:74-82. [PMID: 23672411 DOI: 10.1111/his.12140] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
446 Watanabe T, Asano N, Kitani A, Fuss IJ, Chiba T, Strober W. NOD1-Mediated Mucosal Host Defense against Helicobacter pylori. Int J Inflam. 2010;2010:476482. [PMID: 21152124 DOI: 10.4061/2010/476482] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
447 Kim JS, Shin OR, Kim HK, Cho YS, An CH, Lim KW, Kim SS. Overexpression of protein phosphatase non-receptor type 11 (PTPN11) in gastric carcinomas. Dig Dis Sci. 2010;55:1565-1569. [PMID: 19690960 DOI: 10.1007/s10620-009-0924-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
448 Qureshi AM, Hannigan A, Campbell D, Nixon C, Wilson JB. Chitinase-like proteins are autoantigens in a model of inflammation-promoted incipient neoplasia. Genes Cancer. 2011;2:74-87. [PMID: 21779482 DOI: 10.1177/1947601911402681] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
449 Chang YJ, Byun SW, Kim HK, Cho YS, Kim SS, Kim JI, Kim JK, Jung ES. [DNA double strand breaks in gastric epithelium with Helicobacter pylori infection]. Korean J Gastroenterol 2012;60:79-85. [PMID: 22926118 DOI: 10.4166/kjg.2012.60.2.79] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
450 Wunder C, Churin Y, Winau F, Warnecke D, Vieth M, Lindner B, Zähringer U, Mollenkopf HJ, Heinz E, Meyer TF. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med. 2006;12:1030-1038. [PMID: 16951684 DOI: 10.1038/nm1480] [Cited by in Crossref: 189] [Cited by in F6Publishing: 183] [Article Influence: 11.8] [Reference Citation Analysis]
451 Kacar F, Meteoğlu I, Yasa H, Levi E. Helicobacter pylori-induced changes in the gastric mucosa are associated with mitogen-activated protein kinase (MAPK) activation. Appl Immunohistochem Mol Morphol. 2007;15:224-228. [PMID: 17525639 DOI: 10.1097/01.pai.0000209863.35828.dd] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
452 Suzuki N, Murata-Kamiya N, Yanagiya K, Suda W, Hattori M, Kanda H, Bingo A, Fujii Y, Maeda S, Koike K. Mutual reinforcement of inflammation and carcinogenesis by the Helicobacter pylori CagA oncoprotein. Sci Rep. 2015;5:10024. [PMID: 25944120 DOI: 10.1038/srep10024] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
453 Smith SI, Jolaiya T, Fowora M, Ugiagbe R, Onyekwere C, Agbo I, Lesi O, Palamides P, Adedeji A, Ndububa D, Adekanle O, Adeleye I, Bamidele M, Ngoka F, Ayodeji I, Njom H, Pellicano R. Comparison of polymerase chain reaction-based genotyping of Helicobacter pylori by direct polymerase chain reaction from biopsies and cultures from patients with dyspepsia in Nigeria. Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.19.02558-8] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
454 Oleastro M, Ménard A. The Role of Helicobacter pylori Outer Membrane Proteins in Adherence and Pathogenesis. Biology (Basel) 2013;2:1110-34. [PMID: 24833057 DOI: 10.3390/biology2031110] [Cited by in Crossref: 56] [Cited by in F6Publishing: 65] [Article Influence: 6.2] [Reference Citation Analysis]
455 Matsuoka K, Nishiumi S, Yoshida M, Kodama Y. Effects of Helicobacter pylori on the glutathione-related pathway in gastric epithelial cells. Biochem Biophys Res Commun 2020;526:1118-24. [PMID: 32312521 DOI: 10.1016/j.bbrc.2020.04.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
456 Wang HP, Zhu YL, Shao W. Role of Helicobacter pylori virulence factor cytotoxin-associated gene A in gastric mucosa-associated lymphoid tissue lymphoma. World J Gastroenterol 2013; 19(45): 8219-8226 [PMID: 24363512 DOI: 10.3748/wjg.v19.i45.8219] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
457 IJdo JW, Carlson AC, Kennedy EL. Anaplasma phagocytophilum AnkA is tyrosine-phosphorylated at EPIYA motifs and recruits SHP-1 during early infection. Cell Microbiol 2007;9:1284-96. [PMID: 17250594 DOI: 10.1111/j.1462-5822.2006.00871.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]
458 Zhang XS, Tegtmeyer N, Traube L, Jindal S, Perez-Perez G, Sticht H, Backert S, Blaser MJ. A specific A/T polymorphism in Western tyrosine phosphorylation B-motifs regulates Helicobacter pylori CagA epithelial cell interactions. PLoS Pathog. 2015;11:e1004621. [PMID: 25646814 DOI: 10.1371/journal.ppat.1004621] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 9.4] [Reference Citation Analysis]
459 Lin AS, Dooyema SDR, Frick-Cheng AE, Harvey ML, Suarez G, Loh JT, McDonald WH, McClain MS, Peek RM Jr, Cover TL. Bacterial Energetic Requirements for Helicobacter pylori Cag Type IV Secretion System-Dependent Alterations in Gastric Epithelial Cells. Infect Immun 2020;88:e00790-19. [PMID: 31712269 DOI: 10.1128/IAI.00790-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
460 Inamura K. Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics. Semin Cancer Biol 2021;70:11-23. [PMID: 32580023 DOI: 10.1016/j.semcancer.2020.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
461 Ge R, Sun X, Xiao C, Yin X, Shan W, Chen Z, He Q. Phosphoproteome analysis of the pathogenic bacterium Helicobacter pylori reveals over-representation of tyrosine phosphorylation and multiply phosphorylated proteins. Proteomics 2011;11:1449-61. [DOI: 10.1002/pmic.201000649] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
462 Hyeon J, Lee B, Shin S, Yoo HY, Kim SJ, Kim WS, Park W, Ko Y. Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement. Mod Pathol 2018;31:1418-28. [DOI: 10.1038/s41379-018-0064-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
463 Umeda M, Murata-Kamiya N, Saito Y, Ohba Y, Takahashi M, Hatakeyama M. Helicobacter pylori CagA causes mitotic impairment and induces chromosomal instability. J Biol Chem 2009;284:22166-72. [PMID: 19546211 DOI: 10.1074/jbc.M109.035766] [Cited by in Crossref: 50] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
464 Taube C, Müller A. The role of Helicobacter pylori infection in the development of allergic asthma. Expert Rev Respir Med. 2012;6:441-449. [PMID: 22971068 DOI: 10.1586/ers.12.40] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
465 Zhao Q, Busch B, Jiménez-Soto LF, Ishikawa-Ankerhold H, Massberg S, Terradot L, Fischer W, Haas R. Integrin but not CEACAM receptors are dispensable for Helicobacter pylori CagA translocation. PLoS Pathog 2018;14:e1007359. [PMID: 30365569 DOI: 10.1371/journal.ppat.1007359] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
466 Srivastava AK, Kumar V, Roy BK. Insights from the molecular docking of curcumin to the virulent factors of Helicobacter pylori. Bioinformation 2015;11:447-53. [PMID: 26664028 DOI: 10.6026/97320630011447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
467 Vaziri F, Peerayeh SN, Alebouyeh M, Maghsoudi N, Azimzadeh P, Siadat SD, Zali MR. Novel effects of Helicobacter pylori CagA on key genes of gastric cancer signal transduction: a comparative transfection study. Pathog Dis. 2015;73. [PMID: 25743471 DOI: 10.1093/femspd/ftu021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
468 Nakamura K, Urabe Y, Kagemoto K, Yuge R, Hayashi R, Ono A, Hayes CN, Oka S, Ito M, Nishisaka T, Tanabe K, Arihiro K, Ohdan H, Tanaka S, Chayama K. Genomic Characterization of Non-Invasive Differentiated-Type Gastric Cancer in the Japanese Population. Cancers (Basel) 2020;12:E510. [PMID: 32098350 DOI: 10.3390/cancers12020510] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
469 Hatakeyama M. Malignant Helicobacter pylori-Associated Diseases: Gastric Cancer and MALT Lymphoma. In: Kamiya S, Backert S, editors. Helicobacter pylori in Human Diseases. Cham: Springer International Publishing; 2019. pp. 135-49. [DOI: 10.1007/5584_2019_363] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
470 Hannigan A, Qureshi AM, Nixon C, Tsimbouri PM, Jones S, Philbey AW, Wilson JB. Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo. Mol Cancer 2011;10:11. [PMID: 21291541 DOI: 10.1186/1476-4598-10-11] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
471 Varanat M, Maggi RG, Linder KE, Breitschwerdt EB. Molecular prevalence of Bartonella, Babesia, and hemotropic Mycoplasma sp. in dogs with splenic disease. J Vet Intern Med 2011;25:1284-91. [PMID: 22092618 DOI: 10.1111/j.1939-1676.2011.00811.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
472 Ma J, Hong L, Chen Z, Nie Y, Fan D. Epigenetic regulation of microRNAs in gastric cancer. Dig Dis Sci. 2014;59:716-723. [PMID: 24248419 DOI: 10.1007/s10620-013-2939-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
473 Murata-Kamiya N. Pathophysiological functions of the CagA oncoprotein during infection by Helicobacter pylori. Microbes Infect. 2011;13:799-807. [PMID: 21477660 DOI: 10.1016/j.micinf.2011.03.011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
474 Zhao Y, Wang JW, Tanaka T, Hosono A, Ando R, Tokudome S, Soeripto, Triningsih FE, Triono T, Sumoharjo S, Achwan EWA, Gunawan S, Li YM. Association between TNF-α and IL-1β genotypes vs Helicobacter pylori infection in Indonesia. World J Gastroenterol 2013; 19(46): 8758-8763 [PMID: 24379597 DOI: 10.3748/wjg.v19.i46.8758] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
475 Sastry SK, Elferink LA. Checks and balances: interplay of RTKs and PTPs in cancer progression. Biochem Pharmacol 2011;82:435-40. [PMID: 21704606 DOI: 10.1016/j.bcp.2011.06.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
476 Matsuo Y, Kido Y, Akada J, Shiota S, Binh TT, Trang TTH, Dung HDQ, Tung PH, Tri TD, Thuan NPM, Tam LQ, Nam BC, Khien VV, Yamaoka Y. Novel CagA ELISA exhibits enhanced sensitivity of Helicobacter pylori CagA antibody. World J Gastroenterol 2017; 23(1): 48-59 [PMID: 28104980 DOI: 10.3748/wjg.v23.i1.48] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
477 Akhter Y, Ahmed I, Devi SM, Ahmed N. The co-evolved Helicobacter pylori and gastric cancer: trinity of bacterial virulence, host susceptibility and lifestyle. Infect Agent Cancer 2007;2:2. [PMID: 17201930 DOI: 10.1186/1750-9378-2-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
478 Zhang W, Lu H, Graham DY. An Update on Helicobacter pylori as the Cause of Gastric Cancer. Gastrointest Tumors 2014;1:155-65. [PMID: 26672968 DOI: 10.1159/000365310] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
479 Zhang YL, Lu FY, Wang WB, Zhang YC, Liu YP, Wu Y. Influences of Helicobacter pylori on SHP-2 expression and cytoskeleton in human gastric cancer cells SGC-7901. Shijie Huaren Xiaohua Zazhi 2008; 16(26): 2916-2921 [DOI: 10.11569/wcjd.v16.i26.2916] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
480 Kim BJ, Kim HS, Jang HJ, Kim JH. Helicobacter pylori Eradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials. Gastroenterol Res Pract. 2018;2018:6090878. [PMID: 30402091 DOI: 10.1155/2018/6090878] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
481 Necchi V, Candusso ME, Tava F, Luinetti O, Ventura U, Fiocca R, Ricci V, Solcia E. Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori. Gastroenterology. 2007;132:1009-1023. [PMID: 17383424 DOI: 10.1053/j.gastro.2007.01.049] [Cited by in Crossref: 159] [Cited by in F6Publishing: 160] [Article Influence: 10.6] [Reference Citation Analysis]
482 Khatoon J, Prasad KN, Prakash Rai R, Ghoshal UC, Krishnani N. Association of heterogenicity of Helicobacter pylori cag pathogenicity island with peptic ulcer diseases and gastric cancer. Br J Biomed Sci. 2017;74:121-126. [PMID: 28571523 DOI: 10.1080/09674845.2017.1278887] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
483 Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol. 2010;7:629-641. [PMID: 20938460 DOI: 10.1038/nrgastro.2010.15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
484 Hayashi T, Senda M, Suzuki N, Nishikawa H, Ben C, Tang C, Nagase L, Inoue K, Senda T, Hatakeyama M. Differential Mechanisms for SHP2 Binding and Activation Are Exploited by Geographically Distinct Helicobacter pylori CagA Oncoproteins. Cell Rep 2017;20:2876-90. [PMID: 28930683 DOI: 10.1016/j.celrep.2017.08.080] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 9.8] [Reference Citation Analysis]